Introduction
============

In conditions such as rheumatoid arthritis, diabetes, and hypertension, long-term therapy with chronic preventive maintenance medication (CPMM) is essential for reducing risks of disease progression, comorbidity, and mortality. However, sufficient medication adherence to CPMM is a prerequisite for reducing these risks.[@b1-ppa-8-519]

Medication non-adherence, or the extent to which patients do not take their medications as agreed with their health care provider, averages 50% among patients suffering from chronic diseases in developed countries.[@b2-ppa-8-519] Non-adherence can result in poorer health outcomes and a lower quality of life in patients.[@b3-ppa-8-519] For example, patients who did not adhere to beta-blocker therapy were four and a half times more likely to have complications from coronary heart disease than those who adhered to therapy.[@b4-ppa-8-519] Non-adherence also affects health care utilization. For instance, poorer adherence among elderly patients with moderate-to-severe asthma was associated with a 5% increase in annual physician visits, whereas better adherence was associated with a 20% decrease in annual hospitalization.[@b5-ppa-8-519]

Considering the undesired consequences of non-adherence to CPMM, interventions are needed to improve medication non-adherence. According to the World Health Organization (WHO), possible targets for these interventions can be divided into five domains:[@b2-ppa-8-519] socio-economic factors, health care system factors, condition-related factors, therapy-related factors, and patient-related factors. Although none of the factors within these domains are consistently associated with non-adherence across conditions, some tend to be better predictors of non-adherence than others (like poverty, the nature of the disease, and side-effects).[@b1-ppa-8-519],[@b2-ppa-8-519] Also, psychosocial factors like beliefs about medication, self-efficacy, and social support can be promising intervention targets. These are mostly modifiable (in contrast to factors like poverty or side-effects), and according to reviews of cross-sectional studies, they appear to be associated with non-adherence in various somatic, chronic conditions.[@b6-ppa-8-519]--[@b13-ppa-8-519] Beliefs about medication were the most powerful predictors of adherence (among demographic and medical factors) in one cross-sectional study,[@b9-ppa-8-519] while another cross-sectional study identified low-self-efficacy as a significant predictor of non-adherence across different countries, for example.[@b11-ppa-8-519] However, there is no insight into psychosocial factors predicting non-adherence in longitudinal studies with a longer follow-up period (≥3 months). Such knowledge would be helpful in designing effective adherence interventions in clinical practice.

This is the first review which aims to systematically synthesize evidence of longitudinal associations between psychosocial predictors and CPMM non-adherence across adult patients living in Western countries. Since non- adherence literature is scattered across diseases,[@b14-ppa-8-519] we combined studies from various somatic, chronic conditions to increase the robustness of our findings.

Methods
=======

PRISMA-guidelines were followed in performing this systematic review.[@b15-ppa-8-519] The steps taken regarding data searches, study selection, data extraction, study quality assessment, data synthesis, and data analyses are elaborated below.

Data sources and searches
-------------------------

In March 2011, according to a pre-defined search strategy, four electronic databases (PUBMED, EMBASE, CINAHL, and PsychINFO) were searched for studies up to February 2011. With this search, a first set of studies was included, the reference lists of these studies were hand searched to find additional studies. The studies were also entered into the ISI Web of Knowledge citation index (August 2011). The resulting list of studies, citing one of the initial included studies in our review, was also searched.

The search strategy (see Supplementary Materials) contains key words on medication adherence, chronic, somatic diseases, adults, longitudinal designs, and Western countries. Countries in Africa, Latin-America, South-America, Asia (excluding Indonesia and Japan), and Turkey were considered as non-Western according to Statistics Netherlands.[@b16-ppa-8-519] Non-Western countries were excluded because underlying mechanisms of medication non-adherence could differ from those in Western countries due to socio-economic and cultural differences.[@b17-ppa-8-519]

In this review, we focused on two of the three components of adherence (ie, on initiation and implementation adherence, thus the extent to which a patient's actual medication dosing regimen corresponds with the prescribed dosing regimen from initiation to last dose). We did not include discontinuation of medication.[@b1-ppa-8-519]

As using CPMM terms in the search strategy was unfeasible, we used the corresponding diseases for which the CPMMs were prescribed as search terms instead. The disease terms were selected as follows:

1.  Chronic preventive maintenance medications were defined. CPMMs were regarded as drugs that 1) are intended to be used chronically to prevent the occurrence or worsening of a disease or its complications; and 2) may have an immediate effect, but must also have a long-term effect (\>3 months).

2.  From the full November 2010 Anatomical Therapeutic Chemical Classification System (ATC)-7 medication list of drugs available in the Netherlands, 246 CPMMs (Supplementary Materials) were independently selected by two pharmacists (BvdB and VH). There was an initial agreement of 96% on medications being CPMM. Disagreements were resolved by discussion between the pharmacists.

3.  Disease indications for the 246 CPMMs were subsequently clustered by BvdB according to the International Classification of Diseases (WHO). Finally, 20 disease terms were used in the search strategy.

Study selection
---------------

Studies were selected based on the criteria in [Table 1](#t1-ppa-8-519){ref-type="table"}.

Studies exclusively recruiting subpopulations in special conditions (like prisoners, pregnant women) were excluded. Their results only pertain to a specific group of patients, therefore, including them might have introduced bias into this systematic review.

Two reviewers (BvdB and HZ) independently assessed studies for eligibility in two phases: 1) screening based on title and abstract; and 2) screening based on full text. Disagreements between BvdB and HZ were resolved by discussion; a third reviewer (CvdE) made decisions in case disagreements could not be resolved. Studies in Spanish or Portuguese were judged by LvdA. During the study selection process, three authors were contacted about statistics, outcome measure, or study design to determine eligibility for this review.[@b20-ppa-8-519]--[@b22-ppa-8-519]

Data extraction and quality assessment
--------------------------------------

For data extraction, a literature-based, standard form was developed.[@b23-ppa-8-519],[@b24-ppa-8-519] Information regarding study setting, design, descriptive statistics, measures, and analysis were extracted by HZ; BvdB arbitrarily selected 15% of the included studies to check appropriateness of all extracted data of these studies, and also checked all doubts indicated on the form by HZ.

If multiple adherence measures were presented in one study (eg, about dosing, timing, or taking medication)[@b25-ppa-8-519], we only extracted data about taking medication. Two authors were contacted during the extraction process to check the duration of a follow-up period of ≥3 months[@b26-ppa-8-519] or to explain ambiguities.[@b19-ppa-8-519]

We adapted the framework developed by Hayden et al[@b27-ppa-8-519] to judge methodologic study quality. Our framework contained 23 items divided into six bias domains: study participation, study attrition, prognostic, outcome and confounding measurement, and analyses. Each item was scored as 'yes' (no unacceptable amount of bias introduced), 'partly' (/unsure), and 'no' (unacceptable amount of bias introduced). For every bias domain, a transparent method was used to reach overall judgment about the presence or absence of bias (see [Table S1](#SD2-ppa-8-519){ref-type="supplementary-material"}). Studies with ≥four domains judged as 'yes' were considered high-quality studies; studies with \<four domains were considered low-quality studies.

Using three randomly selected studies not included in the review, the framework was piloted by BvdB and HZ, who also performed the actual quality assessment. Disagreements were resolved by discussion and, when necessary, a third reviewer (CvdE) made final decisions. On the domain level, a weighted extent of agreement between BvdB and HZ (quadratic weighting scheme) was calculated due to the ordinal nature of the scores.[@b28-ppa-8-519],[@b29-ppa-8-519]

Data synthesis and analysis
---------------------------

Because over 70 non-identical psychosocial predictors (non-identical by name and/or measurement instrument) were studied in this review, and because of the variety of instruments used to measure non-adherence, a qualitative instead of a quantitative analysis was considered to be appropriate.[@b30-ppa-8-519] Therefore, the results regarding associations between psychosocial predictors and medication non-adherence were qualitatively synthesized in four steps.

In step 1, psychosocial categories were formulated. Initially, all psychosocial elements as mentioned in general health behavior models and theories[@b31-ppa-8-519],[@b32-ppa-8-519] were listed (HZ). Subsequently, based on consensus, the elements were clustered by HZ and three psychologists (SvD, JV, and LK) resulting in the categories of [Figure 1](#f1-ppa-8-519){ref-type="fig"}.

Next, the psychosocial predictors within the studies of the review were assigned to one of the categories in [Figure 1](#f1-ppa-8-519){ref-type="fig"} (HZ and the psychologists). In this way, the considerable number of single, non-identical predictors was dealt with.

In step 2, for each psychosocial predictor within a category and within a study, the presence of a significant univariate and multivariate association with medication non-adherence was determined (see [Table S2](#SD3-ppa-8-519){ref-type="supplementary-material"}). Statistical significance was set at *P*\<0.05.

In step 3, results within studies were synthesized per psychosocial category. When ≥75% of variables within a single psychosocial category were significantly and consistently (ie, same predictors in same direction) associated with non-adherence, a 'yes' was assigned (ie, association present). When ≥75% of variables were significantly, but inconsistently, associated (eg, four of five predictors in category about depressive symptoms, of which two are positively related to non-adherence and two are negatively related), the term 'conflicting' was assigned. When \<75% of variables were significantly and consistently associated, a 'no' was assigned. Multivariate results were preferably used to synthesize results in this step. When multivariate results were not reported, univariate results were used.

In the fourth and final step, a best evidence synthesis (BES) per psychosocial category between studies was performed to summarize evidence of longitudinal associations between the predictors in the psychosocial categories and medication non-adherence. We defined four levels of evidence as used in previous reviews of longitudinal studies:[@b60-ppa-8-519] --[@b62-ppa-8-519]

1.  Strong evidence: consistent findings (≥75% of studies within psychosocial category report same conclusion about association; ie, 'yes, present' or 'no, not present') in at least two high-quality studies.

2.  Moderate evidence: consistent findings in one high-quality study AND at least two low-quality studies.

3.  Limited evidence: findings in one high-quality study OR consistent findings in at least two low-quality studies.

4.  Conflicting evidence: inconsistent findings in at least two studies irrespective of study quality (ie, \<75% of studies report same conclusion about association). Note that this level of evidence was checked first before assigning strong, moderate or limited evidence level to a category.

The level of evidence was undeterminable when ≤one study of low quality was available for a psychosocial category.

Sensitivity analyses were performed to examine the robustness of findings, regarding the cut-off point for methodological quality, diseases, adherence measurement, and statistical analyses (ie, focusing on univariate analyses only). Also, an additional analysis on single predictors was carried out, since associations between single predictors like 'avoidance coping' and non-adherence could be overshadowed by combining them into a single category with generally non-significant psychosocial predictors, such as hopelessness and confusion. Three steps were taken: 1) all significant predictors (*P*≤0.05) were listed; 2) each of these predictors was grouped with identically named, significant and non-significant predictors; and 3) when at least two studies were available for those predictors, the BES rules were applied.

Results
=======

Study inclusion
---------------

Of 4,732 non-duplicate references, 30 met our inclusion criteria ([Figure 2](#f2-ppa-8-519){ref-type="fig"}).[@b19-ppa-8-519],[@b25-ppa-8-519],[@b26-ppa-8-519],[@b33-ppa-8-519]--[@b59-ppa-8-519] In all, 1,255 records were identified by screening the reference lists and the ISI Web of Knowledge citation index of the initial included studies.

Initially, the percentage of agreement regarding the eligibility of studies was 86% (of the 272 studies selected on title and abstract, agreement was obtained in about 235 studies after reading the full-text). Disagreements were mainly due to misconceptions about psychosocial predictors (eg, clinically diagnosed depression versus symptoms of depression), study design, and adherence measure (ie, discontinuation or execution adherence). For one study,[@b52-ppa-8-519] disagreement could not be resolved by discussion and thus a final decision was made by CvdE.

Study characteristics and quality assessment
--------------------------------------------

[Table 2](#t2-ppa-8-519){ref-type="table"} displays study characteristics, measures, and results. A comprehensive table of measures and results is presented in [Table S2](#SD3-ppa-8-519){ref-type="supplementary-material"}.

The included studies (all based on different data sets) covered CPMMs for asthma, diabetes, heart diseases/hypertension, human immunodeficiency virus (HIV), and organ transplants. Medication type was not explicitly mentioned in four studies,[@b37-ppa-8-519],[@b38-ppa-8-519],[@b45-ppa-8-519],[@b59-ppa-8-519] but we assumed CPMM was used since CPMM is the standard medical treatment for the 20 selected diseases in this review. In most studies, patients were recruited from medical clinics or hospitals and the sample size ranged from 50--1,911. Attrition rates varied from 0%--71%. Participants were predominantly men and often ≥37 years of age and a disease duration of \>2 years. The observation period between baseline and last adherence measurement was ≥3 and \<12 months in ten studies and ≥12 months in 20 studies, with a maximum of 60 months. Medication adherence was mostly measured by self-report (18 studies, predominantly questionnaires); seven studies used a validated adherence questionnaire.[@b33-ppa-8-519],[@b36-ppa-8-519],[@b43-ppa-8-519],[@b46-ppa-8-519],[@b49-ppa-8-519]--[@b51-ppa-8-519] Other adherence measurements were carried out by reviewing medical records or the medication event monitoring system (MEMS). In 15 studies, both univariate and multivariate analyses were reported.

All 30 included studies were judged to be 'low-quality' ([Table S3](#SD4-ppa-8-519){ref-type="supplementary-material"}). This was mainly due to poor descriptions and/or bias regarding the study sample, the use of non-validated questionnaires, the lack of accounting for confounding variables, and a poor description of the data analyses. Most studies, moreover, did not appropriately describe actions taken in case of missing data.

A total of 180 bias domains were judged (30 studies by six domains). Initially, BvdB and HZ fully agreed on 78 domains, partially agreed (ie, 'partly' versus 'no' or 'partly' versus 'yes') on 79 domains and fully disagreed (eg, 'yes' versus 'no') on 23 domains, resulting in a weighted agreement of 76%. Disagreements were caused by poor description of methods, different interpretations of missing data, differences in calculating study attrition rates, and different interpretations regarding the appropriateness of study sample descriptions. On this latter point, disagreements about three studies[@b35-ppa-8-519],[@b48-ppa-8-519],[@b52-ppa-8-519] could not be resolved by discussion between BvdB and HZ and, thus, CvdE made the final decision.

Best evidence synthesis
-----------------------

[Table 3](#t3-ppa-8-519){ref-type="table"} shows there is limited evidence for the absence of a longitudinal association with medication non-adherence in all of the eleven psychosocial subcategories.

### Beliefs and cognitions

Regarding category AI (beliefs and cognitions about medication and treatment), two of nine studies found a longitudinal, multivariate association between having a positive attitude towards taking medication and adherence (odds ratio \[OR\] =1.56, 95% confidence interval \[CI\] 1.18, 2.06),[@b43-ppa-8-519] and between necessity beliefs and concern beliefs about medication and adherence (OR =2.19, 95% CI 1.02, 4.71 and OR =0.45, 95% CI 0.22, 0.96, respectively).[@b49-ppa-8-519] One other study[@b33-ppa-8-519] found univariate associations between necessity and concern beliefs about medication and adherence, but these associations did not hold in the multivariate analysis.

One study demonstrated a longitudinal, multivariate association between low self-efficacy and medication non-adherence;[@b53-ppa-8-519] however, the effect size was small. Univariate, but not multivariate associations between self-efficacy and adherence were demonstrated in two studies.[@b55-ppa-8-519],[@b57-ppa-8-519]

### Coping styles

No univariate and multivariate associations were found between the task-oriented coping style category and medication adherence.

Regarding emotion-oriented coping styles, one of six studies revealed a multivariate association with non-adherence (eg, OR of 9.71 for avoidance coping).[@b56-ppa-8-519] Furthermore, avoidance coping as a single predictor was associated with non-adherence in three of four studies measuring this construct.[@b25-ppa-8-519],[@b40-ppa-8-519],[@b56-ppa-8-519]

### Social influences and social support

Two of the 25 studies demonstrated significant associations between predictors within the category social influences and social support and (non-)adherence, but only one of these studies reported on a multivariate association between having support from a partner and non-adherence (regression coefficient =−0.15, 95% CI −0.25, −0.05).[@b51-ppa-8-519] Receiving practical social support was associated with better adherence as a single predictor.[@b38-ppa-8-519],[@b41-ppa-8-519]

### Personality traits

One of eight studies showed a multivariate, longitudinal association between the category of personality traits and medication non-adherence:[@b26-ppa-8-519] a lower sense of coherence (a global life orientation in which life is perceived as comprehensible, manageable and meaningful)[@b63-ppa-8-519] was associated with greater non-adherence (OR=0.55, CI 0.31--0.96). Associations between other predictors within the personality traits category and non-adherence were lacking.

### Psychological well-being

Regarding categories EI (mood state) and EII (perceived stress/stressors), no associations between predictors in those categories and medication non-adherence could be established for the vast majority of studies (24 out of 29). Two of the five studies which did show significant associations reported on multivariate analyses: the regression coefficient for depressive symptoms was 0.18 (95% CI 0.07, 0.29) in predicting non-adherence;[@b51-ppa-8-519] the standardized beta for health distress was −0.22 (CI not reported) for predicting adherence.[@b59-ppa-8-519]

[Table S2](#SD3-ppa-8-519){ref-type="supplementary-material"} can be consulted for detailed information about associations between single psychosocial predictors and medication adherence/non-adherence.

### Sensitivity analyses

The sensitivity analyses confirmed that, generally, no association was found between the psychosocial categories and medication non-adherence ([Table S4](#SD5-ppa-8-519){ref-type="supplementary-material"}).

The additional analysis on single predictors showed no association between most single, psychosocial predictors and medication non-adherence. However, conflicting evidence was found for having a positive attitude towards taking medication,[@b37-ppa-8-519],[@b43-ppa-8-519] necessity beliefs and concern beliefs about medication,[@b33-ppa-8-519],[@b49-ppa-8-519] self-efficacy in medication-taking,[@b25-ppa-8-519],[@b33-ppa-8-519],[@b43-ppa-8-519],[@b47-ppa-8-519],[@b53-ppa-8-519],[@b54-ppa-8-519] the coping style "planful problem solving",[@b25-ppa-8-519],[@b41-ppa-8-519] and (the number of) stressful (life) events.[@b38-ppa-8-519],[@b42-ppa-8-519],[@b46-ppa-8-519] Limited evidence was found for an association between escape-avoidance coping and medication non-adherence,[@b25-ppa-8-519],[@b41-ppa-8-519],[@b56-ppa-8-519],[@b59-ppa-8-519] and for an association between receiving practical, social support and medication adherence.[@b38-ppa-8-519],[@b41-ppa-8-519]

Discussion
==========

To the best of our knowledge, this is the first systematic review summarizing evidence of longitudinal associations between psychosocial factors and non-adherence to CPMM, irrespective of somatic disease. Due to the low quality of the included studies, limited evidence was found for absence of longitudinal associations between categories of psychosocial predictors and medication non-adherence. In general, findings were robust according to sensitivity analyses.

Our findings of longitudinal associations between psychosocial factors and medication non-adherence are in line with the few conducted cross-sectional studies about associations between medication adherence, coping styles, personality traits, and psychosocial well-being (except depressive symptoms) in somatic conditions. The findings in these cross-sectional studies are ambiguous at best.[@b8-ppa-8-519],[@b64-ppa-8-519]--[@b68-ppa-8-519] For example, an active coping style was associated with medication adherence in some studies[@b8-ppa-8-519],[@b68-ppa-8-519] but not in others,[@b64-ppa-8-519],[@b66-ppa-8-519] and stress was associated with lesser adherence in a study of Holt et al,[@b67-ppa-8-519] but was unrelated to non-adherence in a study of Ediger et al.[@b65-ppa-8-519]

In contrast to coping styles and personality traits, depression is often studied as possible predictor of medication non-adherence. Here, our results are not in line with results from other reviews, reporting depression to be a predictor of medication non-adherence.[@b6-ppa-8-519],[@b69-ppa-8-519]--[@b74-ppa-8-519] Initially, this discrepancy might be explained by the fact that clinical depression is within the scope of most other studies, but beyond the scope of our systematic review since we did not study morbidity as a predictor of non-adherence; instead, we studied depressive symptoms. Second, an explanation might be that those other reviews included studies with mainly cross-sectional designs. Feelings of depression might increase and decrease over the course of a disease. A high degree of depressive feelings might correlate well with non-adherent behavior at that same time, but just might not be predictive of non-adherent behavior in the future due to this changeability. Thus, longitudinal associations between depressive feelings and non-adherence might not be applicable.

This thought might also apply to discrepancies in findings between our review and other reviews on associations between beliefs about medication/treatment, poor social support, and non-adherence. These other reviews underline the importance of beliefs about medication/treatment and poor social support in predicting medication non-adherence[@b6-ppa-8-519],[@b10-ppa-8-519],[@b69-ppa-8-519]--[@b76-ppa-8-519] in contrast to our review findings, but again, those other reviews are mainly based on studies with cross-sectional designs.

In terms of internal validity, a strength of this review is that we, in contrast to others, systematically defined and categorized psychosocial factors. By doing so, we were able to 1) draw a concise number of conclusions about associations between psychosocial predictors and medication non-adherence in a reproducible manner; 2) address the heterogeneity between single, psychosocial predictors; and 3) address an important goal of a systematic review: converging information. The pitfall of categorization (eg, the possibility of overlooking significant associations between certain, single predictors and non-adherence, by pooling them with other types of \[non-significant\] predictors), was avoided by performing an extended sensitivity analysis on single predictors. This analysis revealed our conclusions to be robust for almost all single, psychosocial predictors included in this review.

Another strength of this review is that we systematically synthesized results using a best evidence synthesis in contrast to most other reviews, which tend to be characterized by narrative designs.[@b6-ppa-8-519],[@b10-ppa-8-519],[@b69-ppa-8-519],[@b70-ppa-8-519],[@b73-ppa-8-519],[@b74-ppa-8-519],[@b76-ppa-8-519] Narrative designs often do not rely on systematic methods to assign weight of evidence; eg, by incorporating methodological quality of included studies.[@b77-ppa-8-519] Although no review procedure eliminates the chance that reviewers' biases will affect the conclusions drawn,[@b77-ppa-8-519] the application of a best evidence synthesis makes a review procedure transparent and reproducible.

A limitation of this systematic review is that we used chronic disease terms instead of medication terms in the search strategy and, consequently, we may have missed relevant studies about chronic preventive maintenance medication. However, we assume that the number of missed studies is minimal, since diseases are usually mentioned in medication adherence studies.

Another limitation could be the use of results of univariate analyses to draw conclusions about associations in the absence of multivariate analysis data, as univariate analyses could lead to an overestimating of the strength of associations. However, our sensitivity analyses on data from univariate analyses confirmed the robustness of our findings.

Concerning external validity, a strong feature of this review is that it focused exclusively on longitudinal associations between psychosocial predictors and medication non-adherence, thereby providing insight into the temporality and robustness of associations. However, only 5 of the 30 studies included in our review corrected for baseline non-adherence.[@b34-ppa-8-519],[@b50-ppa-8-519],[@b53-ppa-8-519],[@b58-ppa-8-519],[@b59-ppa-8-519] Failure to account for baseline non-adherence when suggesting predictive longitudinal associations is considered a liberal approach,[@b78-ppa-8-519] since baseline non-adherence is likely to explain a substantial part of the variance in non-adherence over time. Because we did not find any associations using a liberal approach, however, we believe it is unlikely that handling a strict longitudinal approach in this review would have altered our findings.

Another limitation concerning external validity is that the poor quality of the included studies prevented us from drawing firm conclusions about the lack of associations between psychosocial predictors and medication adherence The lack of a gold standard for adherence measurement[@b73-ppa-8-519] also restricts the validity of our findings. The adherence measures used in the included studies of this review (self-report, refill data, and electronic monitoring) do not measure actual ingestion, and the use of self-report and electronic monitoring might have introduced response bias because of participants' awareness of the measurements. However, all medication adherence related research has to deal with the limitations of adherence measurements. For now, our review provides the best evidence currently available, and clearly demonstrates the need for more high-quality, longitudinal research into associations between psychosocial predictors and medication non-adherence.

Two recommendations for future research can be made. First, future longitudinal research into psychosocial predictors of medication non-adherence should be of high quality. Researchers should, for example, use valid measures of psychosocial predictors and medication non-adherence and should thoroughly describe which steps were performed in the study, especially those relating to handling missing data and avoiding bias.

Second, the research gap in longitudinal studies into associations between psychosocial predictors and medication non- adherence in patients with conditions such as rheumatic diseases, migraine disorders, gout, glaucoma, and stomach ulcers (see Supplementary Materials) should be complemented. Although we assume that review findings will also apply to these diseases, this assumption needs to be confirmed.

The conclusion of this systematic review is that there is limited evidence for absence of longitudinal associations between psychosocial predictors and medication non-adherence. Consequently, our results do not provide psychosocial targets for the development of new interventions in clinical practice. However, the usefulness of psychosocial predictors in improving medication adherence should not be ruled out, as more high-quality research is needed to confirm or refute the conclusion of this review. Such future research could also further explore the associations found in this review between escape-avoidance coping and medication non-adherence, and between receiving practical, social support and medication adherence.

Supplementary materials
=======================

Pubmed search strategy
----------------------

(((adult\[MeSH Terms\] OR mature\[tw\] OR adult\[tw\])

AND

((Ischaemic heart diseases\[TW\] OR angina pectoris\[TW\] OR Myocardial Ischemia\[TW\] OR asthma\[TW\] OR Diabetes mellitus\[TW\] OR diabetes mellitus\[TW\] OR hypercholesterolaemia\[TW\] OR hyperlipidaemia\[TW\] OR Dyslipidemias\[TW\] OR Gastric ulcer\[TW\] OR Duodenal ulcer\[TW\] OR Stomach Ulcer\[TW\] OR glaucoma\[TW\] OR glaucoma\[TW\] OR heart failure\[TW\] OR Heart failure\[TW\] OR arrhythmias\[TW\] OR Arrhythmias, Cardiac\[TW\] OR "Human immunodeficiency virus" OR HIV disease\[TW\] OR HIV-disease\[TW\] OR HIV infections\[TW\] OR HIV-infections\[TW\] OR Hypertensive diseases\[TW\] OR Hypertension\[TW\] OR Ulcerative colitis\[TW\] OR Crohn's disease\[TW\] OR Inflammatory Bowel Diseases\[TW\] OR Arthropathies\[TW\] OR gout\[TW\] OR Malignant neoplasm of breast\[TW\] OR Breast Neoplasms\[TW\] OR Hereditary angioedema\[TW\] OR Angioedemas, Hereditary\[TW\] OR transplantation\[TW\] OR Organ Transplantation\[TW\] OR migraine\[TW\] OR Migraine Disorders\[TW\] OR osteoporosis\[TW\] OR arthropathy\[TW\] OR Systemic connective tissue disorders\[TW\] OR psoriatic arthropathy\[TW\] OR rheumatoid arthritis\[TW\] OR Systemic lupus erythematosus\[TW\] OR Systemic sclerosis\[TW\] OR Arthritis, Psoriatic\[TW\] OR Arthritis, Rheumatoid\[TW\] OR Lupus Erythematosus, Systemic\[TW\] OR Scleroderma, Systemic\[TW\] OR Arterial embolism\[TW\] OR thrombosis\[TW\] OR venous embolism\[TW\] OR Embolism and Thrombosis\[TW\] OR Paget Disease\[TW\] OR Osteitis Deformans\[TW\]) OR (Myocardial Ischemia\[MH\] OR asthma\[MH\] OR diabetes mellitus\[MH\] OR Dyslipidemias\[MH\] OR Stomach Ulcer\[MH\] OR glaucoma\[MH\] OR Heart failure\[MH\] OR Arrhythmias, Cardiac\[MH\] OR HIV infections\[MH\] OR Hypertension\[MH\] OR Inflammatory Bowel Diseases\[MH\] OR gout\[MH\] OR Breast Neoplasms\[MH\] OR Angioedemas, Hereditary\[MH\] OR Organ Transplantation\[MH\] OR Migraine Disorders\[MH\] OR osteoporosis\[MH\] OR Arthritis, Psoriatic\[MH\] OR Arthritis, Rheumatoid\[MH\] OR Lupus Erythematosus, Systemic\[MH\] OR Scleroderma, Systemic\[MH\] OR Embolism and Thrombosis\[MH\] OR Osteitis Deformans\[MH\]))

AND

((medication adherence\[MH\] OR patient compliance\[MH\]) OR (medication compliance\[TW\] OR medication noncompliance\[TW\] OR medication non compliance\[TW\] OR medication noncompliance\[TW\] OR medication adherence\[TW\] OR medication non-adherence\[TW\] OR medication non adherence\[TW\] OR medication nonadherence\[TW\] OR medication adherance\[TW\] OR medication non-adherance\[TW\] OR medication non adherance\[TW\] OR medication nonadherance\[TW\] OR medication persistence\[TW\] OR medication non-persistence\[TW\] OR medication non persistence\[TW\] OR medication nonpersistence\[TW\] OR medication persistance\[TW\] OR medication non-persistance\[TW\] OR medication non persistance\[TW\] OR medication nonpersistance\[TW\] OR medicine compliance\[TW\] OR medicine non-compliance\[TW\] OR medicine non compliance\[TW\] OR medicine noncompliance\[TW\] OR medicine adherence\[TW\] OR medicine non-adherence\[TW\] OR medicine non adherence\[TW\] OR medicine nonadherence\[TW\] OR medicine adherance\[TW\] OR medicine non-adherance\[TW\] OR medicine non adherance\[TW\] OR medicine nonadherance\[TW\] OR medicine persistence\[TW\] OR medicine non-persistence\[TW\] OR medicine non persistence\[TW\] OR medicine nonpersistence\[TW\] OR medicine persistance\[TW\] OR medicine non-persistance\[TW\] OR medicine non persistance\[TW\] OR medicine nonpersistance\[TW\] OR medical compliance\[TW\] OR medical non-compliance\[TW\] OR medical non compliance\[TW\] OR medical noncompliance\[TW\] OR medical adherence\[TW\] OR medical non-adherence\[TW\] OR medical non adherence\[TW\] OR medical nonadherence\[TW\] OR medical adherance\[TW\] OR medical non-adherance\[TW\] OR medical non adherance\[TW\] OR medical nonadherance\[TW\] OR medical persistence\[TW\] OR medical non-persistence\[TW\] OR medical non persistence\[TW\] OR medical nonpersistence\[TW\] OR medical persistance\[TW\] OR medical non-persistance\[TW\] OR medical non persistance\[TW\] OR medical nonpersistance\[TW\] OR drug compliance\[TW\] OR drug non-compliance\[TW\] OR drug non compliance\[TW\] OR drug noncompliance\[TW\] OR drug adherence\[TW\] OR drug non-adherence\[TW\] OR drug non adherence\[TW\] OR drug nonadherence\[TW\] OR drug adherance\[TW\] OR drug non-adherance\[TW\] OR drug non adherance\[TW\] OR drug nonadherance\[TW\] OR drug persistence\[TW\] OR drug non-persistence\[TW\] OR drug non persistence\[TW\] OR drug nonpersistence\[TW\] OR drug persistance\[TW\] OR drug non-persistance\[TW\] OR drug non persistance\[TW\] OR drug nonpersistance\[TW\] OR drugs compliance\[TW\] OR drugs non-compliance\[TW\] OR drugs non compliance\[TW\] OR drugs noncompliance\[TW\] OR drugs adherence\[TW\] OR drugs non-adherence\[TW\] OR drugs non adherence\[TW\] OR drugs nonadherence\[TW\] OR drugs adherance\[TW\] OR drugs non-adherance\[TW\] OR drugs non adherance\[TW\] OR drugs nonadherance\[TW\] OR drugs persistence\[TW\] OR drugs non-persistence\[TW\] OR drugs non persistence\[TW\] OR drugs nonpersistence\[TW\] OR drugs persistance\[TW\] OR drugs non-persistance\[TW\] OR drugs non persistance\[TW\] OR drugs nonpersistance\[TW\]))

AND

(Prospective Studies\[MH\] OR Longitudinal Studies\[MH\] OR Cohort Studies\[MH\] OR Follow-up Studies\[MH\] OR Retrospective Studies\[MH\] OR Prospective Studies\[TIAB\] OR Longitudinal Studies\[TIAB\] OR Cohort Studies\[TIAB\] OR Follow-up Studies\[TIAB\] OR Retrospective Studies\[TIAB\] OR observational stud\*\[TIAB\] OR predict\*\[TW\] OR prognos\*\[TW\] OR prognostic factor\*\[TW\] OR course\[TW\] OR determinant\*\[TW\]))

NOT

"Africa"\[Mesh\] OR "Latin America"\[Mesh\] OR "Asia, Central"\[Mesh\] OR "Borneo"\[Mesh\] OR "Brunei"\[Mesh\] OR "Cambodia"\[Mesh\] OR "East Timor"\[Mesh\] OR "Laos"\[Mesh\] OR "Malaysia"\[Mesh\] OR "Mekong Valley"\[Mesh\] OR "Myanmar"\[Mesh\] OR "Philippines"\[Mesh\] OR "Singapore"\[Mesh\] OR "Thailand"\[Mesh\] OR "Vietnam"\[Mesh\] OR "Bangladesh"\[Mesh\] OR "Bhutan"\[Mesh\] OR "India"\[Mesh\] OR "Afghanistan"\[Mesh\] OR "Bahrain"\[Mesh\] OR "Iran"\[Mesh\] OR "Egypt"\[Mesh\] OR "Iraq"\[Mesh\] OR "Israel"\[Mesh\] OR "Jordan"\[Mesh\] OR "Kuwait"\[Mesh\] OR "Lebanon"\[Mesh\] OR "Oman"\[Mesh\] OR "Qatar"\[Mesh\] OR "Saudi Arabia"\[Mesh\] OR "Syria"\[Mesh\] OR "United Arab Emirates"\[Mesh\] OR "Yemen"\[Mesh\] OR "Nepal"\[Mesh\] OR "Pakistan"\[Mesh\] OR "Sri Lanka"\[Mesh\] OR "China"\[Mesh\] OR "Korea"\[Mesh\] OR "Mongolia"\[Mesh\] OR "Taiwan"\[Mesh\]

NOT

(youth\[TIAB\] OR child\*\[TIAB\])

NOT

(Clinical Trial\[MH\] OR case reports\[PT\] OR review\[PT\] OR meta-analysis\[MH\] OR Cross-sectional Studies\[MH\] OR Case-control Studies\[MesH:NoExp\] OR Clinical Trial\*\[PT\] OR case report\*\[PT\] OR review\*\[PT\] OR meta-analys\*\[PT\] OR case report\*\[TIAB\] OR case-report\*\[TIAB\] OR review\*\[TIAB\] OR systematic review\*\[TIAB\] OR meta-analys\*\[TIAB\] OR randomized controlled trial\*\[TIAB\] OR randomised controlled trial\*\[TIAB\] OR clinical trial\*\[TIAB\] OR controlled clinical trial\*\[TIAB\] OR cross-sectional\*\[TIAB\] OR cross sectional\*\[TIAB\] OR Case-control Studies\[TIAB\] OR case-control\[TIAB\] OR case control\[TIAB\] OR Editorial\[ptyp\] OR Letter\[ptyp\] OR Comment\[ptyp\] OR Interview\[ptyp\] OR Newspaper Article\[ptyp\])

Chronic preventive maintenance medication
-----------------------------------------

  --------- -------------------------
  A02BA01   Cimetidine
  A02BA02   Ranitidine
  A02BA03   Famotidine
  A02BA04   Nizatidine
  A02BA07   Ranitidinebismutcitrate
  A02BB01   Misoprostol
  A02BC01   Omeprazole
  A02BC02   Pantoprazole
  A02BC03   Lansoprazole
  A02BC04   Rabeprazole
  A02BC05   Esomeprazole
  A07EA04   Betamethasone
  A07EA06   Budesonide
  A07EA07   Beclomethasone
  A07EC01   Sulphasalazine
  A07EC02   Mesalazine
  A07EC03   Olsalazine
  A10A      Insulin
  A10BA02   Metformin
  A10BB01   Glibenclamide
  A10BB03   Tolbutamide
  A10BB07   Glipizide
  A10BB09   Gliclazide
  A10BB12   Glimepiride
  A10BF01   Acarbose
  A10BG02   Rosiglitazone
  A10BG03   Pioglitazone
  A10BH01   Sitagliptine
  A10BX02   Repaglinide
  A11CC03   Alfacalcidol
  A11CC04   Calcitriol
  A11CC05   Colecalciferol
  A12AA01   Calciumphosphate
  A12AA02   Calciumglubionate
  A12AA03   Calciumgluconate
  A12AA04   Calciumcarbonate
  A12AA05   Calciumlactate
  A12AA07   Calciumchloride
  A12AA12   Calciumacetate
  A12AA30   Calciumlevulinate
  B01AA03   Warfarin
  B01AA04   Fenprocoumon
  B01AA07   Acenocoumarol
  B01AC04   Clopidogrel
  B01AC06   Acetylsalicylic acid
  B01AC07   Dipyridamole
  B01AC08   Carbasalate calcium
  B01AC09   Epoprostenol
  B01AC21   Treprostinil
  B03BB01   Folic acid
  C01AA05   Digoxin
  C01BA01   Quinine
  C01BA02   Procainamide
  C01BA03   Disopyramide
  C01BB01   Lidocaine
  C01BB04   Aprindine
  C01BC03   Propafenone
  C01BC04   Flecainide
  C01BD01   Amiodarone
  C01DA08   Isosorbidedinitrate
  C01DA14   Isosorbidemononitrate
  C01DX16   Nicorandil
  C01EB17   Ivabradine
  C02AB01   Methyldopa
  C02CA01   Prazosin
  C02CA04   Doxazosin
  C02CA06   Urapidil
  C02DB02   Hydralazine
  C02DC01   Minoxidil
  C02KD01   Ketanserin
  C02KX01   Bosentan
  C02KX03   Sitaxentan
  C03AA03   Hydrochloorthiazide
  C03AA04   Chlorthiazide
  C03BA04   Chlortalidone
  C03BA11   Indapamide
  C03CA01   Furosemide
  C03CA02   Bumetanide
  C03DA01   Spironolactone
  C03DA04   Eplerenone
  C03DB01   Amiloride
  C03DB02   Triamterene
  C04AC01   Nicotinic acid
  C04AD02   Xantinolnicotinate
  C07AA02   Oxprenolol
  C07AA03   Pindolol
  C07AA05   Propranolol
  C07AA07   Sotalol
  C07AB02   Metoprolol
  C07AB03   Atenolol
  C07AB04   Acebutolol
  C07AB05   Betaxolol
  C07AB07   Bisoprolol
  C07AB08   Celiprolol
  C07AB12   Nebivolol
  C07AG01   Labetalol
  C07AG02   Carvedilol
  C08CA01   Amlodipine
  C08CA02   Felodipine
  C08CA03   Isradipine
  C08CA04   Nicardipine
  C08CA05   Nifedipine
  C08CA06   Nimodipine
  C08CA07   Nisoldipine
  C08CA08   Nitrendipine
  C08CA09   Lacidipine
  C08CA12   Barnidipine
  C08CA13   Lercanidipine
  C08DA01   Verapamil
  C08DB01   Diltiazem
  C09AA01   Captopril
  C09AA03   Lisinopril
  C09AA04   Perindopril
  C09AA05   Ramipril
  C09AA06   Quinapril
  C09AA07   Benazepril
  C09AA08   Cilazapril
  C09AA09   Fosinopril
  C09AA10   Trandolapril
  C09AA15   Zofenopril
  C09CA01   Losartan
  C09CA02   Eprosartan
  C09CA03   Valsartan
  C09CA04   Irbesartan
  C09CA06   Candesartan
  C09CA07   Telmisartan
  C09CA08   Olmesartan
  C10AA01   Simvastatin
  C10AA03   Pravastatin
  C10AA04   Fluvastatin
  C10AA05   Atorvastatin
  C10AA07   Rosuvastatin
  C10AB01   Clofibrate
  C10AB02   Bezafibrate
  C10AB04   Gemfibrozil
  C10AB08   Ciprofibrate
  C10AC01   Colestyramine
  C10AC02   Colestipol
  C10AC04   Colesevelam
  C10AD02   Nicotinic acid
  C10AD06   Acipimox
  C10AX09   Ezetimib
  G03XA01   Danazol
  G03XC01   Raloxifene
  G04BD02   Flavoxate
  G04BD04   Oxybutynin
  G04BD07   Tolterodine
  G04BD08   Solifenacin
  G04BD10   Darifenacin
  G04CA01   Alfuzosin
  G04CA02   Tamsulosin
  G04CA03   Terazosin
  G04CB01   Finasterid
  G04CB02   Dutasterid
  H02AA02   Fludrocortisone
  H02AB01   Betamethasone
  H02AB02   Dexamethasone
  H02AB04   Methylprednisolone
  H02AB06   Prednisolone
  H02AB07   Prednisone
  H02AB08   Triamcinolone
  H02AB09   Hydrocortisone
  H02AB10   Cortisone
  J05AE01   Saquinavir
  J05AE02   Indinavir
  J05AE03   Ritonavir
  J05AE04   Nelfinavir
  J05AE05   Amprenavir
  J05AE06   Lopinavir
  J05AE07   Fosamprenavir
  J05AE08   Atazanavir
  J05AE09   Tipranavir
  J05AE10   Darunavir
  J05AF01   Zidovudine
  J05AF02   Didanosine
  J05AF03   Zalcitabine
  J05AF04   Stavudine
  J05AF05   Lamivudin
  J05AF06   Abacavir
  J05AF07   Tenofovir
  J05AF08   Adefovir
  J05AF09   Emtricitabine
  J05AF10   Entecavir
  J05AF11   Telbivudine
  J05AG01   Nevirapine
  J05AG03   Efavirenz
  J05AX07   Enfuvirtide
  L01AA01   Cyclophosphamide
  L01BA01   Methotrexate
  L02BG01   Aminoglutethimide
  L02BG03   Anastrozole
  L02BG04   Letrozole
  L04AA06   Mycophenol acid
  L04AA10   Sirolimus
  L04AA13   Leflunomide
  L04AA18   Everolimus
  L04AB01   Etanercept
  L04AB02   Infliximab
  L04AB04   Adalimumab
  L04AC03   Anakinra
  L04AD01   Ciclosporine
  L04AD02   Tacrolimus
  L04AX01   Azathioprine
  L04AX03   Methotrexate
  M01CB01   Aurothiomalate
  M01CB03   Auranofin
  M01CC01   Penicillamine
  M04AA01   Allopurinol
  M04AB01   Probenecid
  M04AB03   Benzbromarone
  M05BA01   Etidronate
  M05BA02   Clodronate
  M05BA03   Pamidronate
  M05BA04   Alendronate
  M05BA05   Tiludronate
  M05BA06   Ibandronate
  M05BA07   Risedronate
  M05BA08   Zoledronate
  M05BX03   Strontiumranelate
  N02CX01   Pizotifen
  N02CX02   Clonidine
  R03BA01   Beclomethasone
  R03BA02   Budesonide
  R03BA05   Fluticasone
  R03BA08   Ciclesonid
  R03BC01   Cromolyn sodium
  R03BC03   Nedocromil
  R03DC03   Montelukast
  S01EA02   Dipivefrine
  S01EA03   Apraclonidine
  S01EA05   Brimonidine
  S01EA51   Epinephrine
  S01EB01   Pilocarpine
  S01EB08   Aceclidine
  S01EC01   Acetazolamide
  S01EC03   Dorzolamide
  S01EC04   Brinzolamide
  S01ED01   Timolol
  S01ED02   Betaxolol
  S01ED03   Levobunolol
  S01ED04   Metipranolol
  S01ED05   Carteolol
  S01ED06   Befunolol
  S01EE01   Latanoprost
  S01EE03   Bimatoprost
  S01EE04   Travoprost
  --------- -------------------------

###### 

Framework for judging methodological quality

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Bias domain                                                                                                                                                                                                                                                                                                                                                          Criterion                                                                                                                                                                                                                                                                                                                                                                                                                                                          Score                                                                Judgment                                              Final score
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------- ----------------------------------------------------- -------------
  1\. Study participation                                                                                                                                                                                                                                                                                                                                              1.1. The setting of the source population is adequately described by key characteristics (setting/geographical location)                                                                                                                                                                                                                                                                                                                                           ○ Yes ○ Partly ○ No                                                  5 × yes = yes\                                        ○ Yes\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               1 × no = no\                                          ○ Partly\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Else = partly                                         ○ No

  1.2. The (baseline) study sample is adequately described by key characteristics (descriptive data about age, sex, diagnosis, disease duration and medication type/group), and no unacceptable level of bias is present                                                                                                                                               ○ Yes ○ Partly ○ No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  1.3. The method of recruitment or sampling is adequately described. If method of recruitment is not 'consecutive', then, for example, descriptions are given about the sampling frame, numbers, methods to identify the sample (such as a description of referral patterns in health care) and period of recruitment, and no unacceptable level of bias is present   ○ Yes ○ Partly ○ No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  1.4. Inclusion and exclusion criteria are adequately described, and no unacceptable level of bias is present                                                                                                                                                                                                                                                         ○ Yes ○ Partly ○ No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  1.5. There is adequate participation in the study by eligible individuals (power analysis is described or the sample size (n) is adequate in relation to the number of prognostic variables (K) in the statistical analyses (ratio n:K exceeds 10:1)                                                                                                                 ○ Yes ○ Partly ○ No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  2\. Study attrition                                                                                                                                                                                                                                                                                                                                                  2.1. Response rate (ie, proportion of study sample completing the study and providing outcome data) is adequate\                                                                                                                                                                                                                                                                                                                                                   ○ Yes ○ Partly ○ No                                                  2.1 yes = yes (you can leave 2.2 open)\               ○ Yes\
                                                                                                                                                                                                                                                                                                                                                                       If study sample size ≤50 participants: 'yes' when total number of participants lost to follow-up was \<10% at follow-up ≥three months. 'Partly': if this percentage was between 10% and 20%. 'No': if this percentage was ≥20% If study sample size \>50 participants: 'yes', when total number of participants lost to follow-up was \<20% at follow-up \$three months. 'Partly': if this percentage was between 20% and 33%. 'No': if this percentage was ≥33%                                                                        2.1 no = no\                                          ○ Partly\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               OR 2.1 partly, 2.2 no = no\                           ○ No
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Else = partly                                         

  2.2. Attempts to collect information about participants who dropped out of the study are described: 1) reasons for loss to follow-up are provided OR 2) participants lost to follow-up are adequately described by key characteristics and outcomes. No unacceptable level of bias is present                                                                        ○ Yes ○ Partly ○ No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  3\. Prognostic factor measurement                                                                                                                                                                                                                                                                                                                                    3.1. A clear description of the main prognostic factors is provided (not covariates) AND/OR measures/methods regarding the main prognostic factors, at baseline and follow-up are adequately described to allow assessment of their validity and reliability. No unacceptable level of bias is present\                                                                                                                                                            ○ Yes ○ Partly ○ No                                                  4 × yes = yes\                                        ○ Yes\
                                                                                                                                                                                                                                                                                                                                                                        ○ Objective measures (such as number of life-changing events) and clear description is 'yes'. Poor/no description = 'partly'\                                                                                                                                                                                                                                                                                                                                                                                                          3.1 or 3.2 no = no\                                   ○ Partly\
                                                                                                                                                                                                                                                                                                                                                                        ○ Validated, subjective measures (eg, opinions) and clear description = 'yes'. Poor/no description = 'partly'\                                                                                                                                                                                                                                                                                                                                                                                                                         OR 3.1 or 3.2 partly (no no's), 3.3 or 3.4 no = no\   ○ No
                                                                                                                                                                                                                                                                                                                                                                        ○ Non-validated, subjective measures and clear description = 'partly'. Poor/no description = 'no'                                                                                                                                                                                                                                                                                                                                                                                                                                      Else = partly                                         

  3.2. The method and setting of measurement are the same for all study participants at baseline and follow-up                                                                                                                                                                                                                                                         ○ Yes ○ Partly ○ No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  3.3. Continuous variables are reported or appropriate cut-off points are used                                                                                                                                                                                                                                                                                        ○ Yes ○ Partly ○ No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  3.4. Authors appropriately described and dealt with missing data on prognostic factors                                                                                                                                                                                                                                                                               ○ Yes ○ Partly ○ No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  4\. Outcome measurement                                                                                                                                                                                                                                                                                                                                              4.1. A clear description of medication adherence is provided AND/OR measures/methods of medication adherence (at baseline and follow-up) are adequately described, to allow assessment of their validity and reliability. No unacceptable level of bias is present\                                                                                                                                                                                                ○ Yes ○ Partly ○ No                                                  3 × yes = yes\                                        ○ Yes\
                                                                                                                                                                                                                                                                                                                                                                        ○ Objective measures (such as pill count, refill rates, MEMS) and clear description = 'yes'. Poor/no description is 'partly'\                                                                                                                                                                                                                                                                                                                                                                                                          4.1 or 4.2 no = no\                                   ○ Partly\
                                                                                                                                                                                                                                                                                                                                                                        ○ Validated, subjective measures (eg, questionnaires) and clear description = 'yes'. Poor/no description = 'partly'\                                                                                                                                                                                                                                                                                                                                                                                                                   OR 4.1 or 4.2 partly (no no's), 4.3 no = no\          ○ No
                                                                                                                                                                                                                                                                                                                                                                        ○ Non-validated, subjective measures and clear description = 'partly'. Poor/no description = 'no'                                                                                                                                                                                                                                                                                                                                                                                                                                      Else = partly                                         

  4.2. The method and setting of measurement are the same for all study participants at baseline (if measured) and follow-up                                                                                                                                                                                                                                           ○ Yes ○ Partly ○ No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  4.3. Authors appropriately described and dealt with missing outcome data                                                                                                                                                                                                                                                                                             ○ Yes ○ Partly ○ No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  5\. Confounding measurement and account                                                                                                                                                                                                                                                                                                                              5.1. The most important confounders are measured\                                                                                                                                                                                                                                                                                                                                                                                                                  ○ Yes ○ Partly ○ No                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                       Examples of possible confounders: age; socioeconomic status/educational level/financial situation/illiteracy; social support/networks; depression/anxiety/emotional distress/lack of acceptance of disease; fatigue/pain/physical disability; self-efficacy/coping; regimen complexity/route of administration/number of medications; satisfaction with patient-provider relationship/autonomy                                                                                                                                                                                                

  5.2. A clear description of the most important confounders measured is provided AND/OR measures/methods of the most important confounders (at baseline) are adequately described to allow assessment of their validity and reliability. No unacceptable level of bias is present\                                                                                    ○ Yes ○ Partly ○ No                                                                                                                                                                                                                                                                                                                                                                                                                                                One of 5.1 to 5.4 = no (if 5.1 no, you can leave 5.2 to 5.5 open)\   ○ Yes\                                                
   ○ Objective measures (such as age, sex) and clear description = 'yes'. Poor/no description is 'partly'\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                OR 5.1 to 5.4 partly, 5.5 no = no\                                   ○ Partly\                                             
   ○ Validated, subjective measures (eg, opinions) and clear description = 'yes'. Poor/no description = 'partly'\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         All partly = partly\                                                 ○ No                                                  
   ○ Non-validated, subjective measures and clear description = 'partly'. Poor/no description = 'no'                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      OR 5.1 to 5.4 partly, 5.5 yes = partly\                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          OR none of 5.1 to 5.4 no, 5.5 no = partly\                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          OR 5.1 to 5.4 yes, 5.5 not yes = partly\                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Else = yes                                                                                                                 

  5.3. The method and setting of confounding measurement are the same for all study participants at baseline                                                                                                                                                                                                                                                           ○ Yes ○ Partly ○ No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  5.4. Important potential confounders are accounted for in the study design (eg, matching for key variables/restriction) OR in analysis (stratification/multivariate techniques)                                                                                                                                                                                      ○ Yes ○ Partly ○ No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  5.5. Authors appropriately described and dealt with missing confounding data                                                                                                                                                                                                                                                                                         ○ Yes ○ Partly ○ No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  6\. Analysis                                                                                                                                                                                                                                                                                                                                                         6.1. There is sufficient presentation of data to assess the adequacy of the analysis\                                                                                                                                                                                                                                                                                                                                                                              ○ Yes ○ Partly ○ No                                                  4 × yes = yes\                                        ○ Yes\
                                                                                                                                                                                                                                                                                                                                                                       'Yes', if main findings of the study and statistical methods used are clearly described: simple outcome data, crude data and estimates of random variability should be reported, so that the reader can check the major analyses and conclusions                                                                                                                                                                                                                                                                                        At least 1 × no = no\                                 ○ Partly\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Else = partly                                         ○ No

  6.2. The statistical tests used to assess the main outcome are appropriate\                                                                                                                                                                                                                                                                                          ○ Yes ○ Partly ○ No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  For example, non-parametric methods should be used for small sample sizes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  6.3. The strategy for model building (ie, inclusion of variables) is appropriate, and is based on conceptual thoughts, a framework or a model\                                                                                                                                                                                                                       ○ Yes ○ Partly ○ No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  For example: variables that do not correlate with the main outcome of interest are not used in multivariate analysis. Proper variables are entered in logical steps into the multivariate model                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  6.4. The selected model is adequate for the design of the study\                                                                                                                                                                                                                                                                                                     ○ Yes ○ Partly ○ No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  For example: in repeated measures, a repeated-measure model should be used. If outcome is binominal, logistic regression should be used, etcetera. If delta outcome is being investigated, models should to be adjusted for baseline outcome values                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

explanation of measures and results[\*](#tfn17-ppa-8-519){ref-type="table-fn"}

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  First author                                                                                                                                       Setting, n patients                                                                                                                                           Measures                                                                                                                                                                                          Psychcat[\|\|](#tfn21-ppa-8-519){ref-type="table-fn"}                                                                                                                   Results[¶](#tfn22-ppa-8-519){ref-type="table-fn"}   Direction of association (regarding adherence)[\*\*](#tfn23-ppa-8-519){ref-type="table-fn"}                                                                                                           N domains bias free[††](#tfn24-ppa-8-519){ref-type="table-fn"}               
  -------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------- ----------- --------
  **Asthma (inhaled corticosteroids)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Ponieman[@b79-ppa-8-519]                                                                                                                           USA; patients from general internal medicine clinic, n=261                                                                                                    Adherence by self-report (MARS), 3 months                                                                                                                                                         (Items derived from BMQ and Self-Regulation Theory): concerns beliefs: worried about side effects of ICS?\                                                              AI                                                  OR =0.3 (0.2, 0.7), *P*\<0.05                                                                                                                                                                         OR =0.52 (0.36, 0.74), *P*\<0.001                                U: −\       0 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Concerns beliefs: worried about getting addicted to ICS?                                                                                                                                                                                                                                                                                                                                                                                                                                           M: −        

  Concerns beliefs: if I use ICS all the time they will stop working                                                                                 AI                                                                                                                                                            OR =0.4 (0.2, 0.8), *P*\<0.05                                                                                                                                                                     NS[‡‡](#tfn25-ppa-8-519){ref-type="table-fn"}                                                                                                                           U: −\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Necessity beliefs: important to use ICS when symptomatic?                                                                                          AI                                                                                                                                                            OR =0.4 (0.2, 0.9), *P*\<0.05                                                                                                                                                                     NS[‡‡](#tfn25-ppa-8-519){ref-type="table-fn"}                                                                                                                           U: −\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Necessity beliefs: important to use ICS when asymptomatic?                                                                                         AI                                                                                                                                                            NS                                                                                                                                                                                                NS[‡‡](#tfn25-ppa-8-519){ref-type="table-fn"}                                                                                                                           U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Self-efficacy: confident in ability to use ICS as prescribed                                                                                       AI                                                                                                                                                            OR =5.8 (2.3, 14.6), *P*\<0.05                                                                                                                                                                    OR =4.15 (2.54, 6.77), *P*\<0.001                                                                                                                                       U: +\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: +                                                                                                                                                                                                                                                                                                                                   

  Self-efficacy: confident in ability to control asthma                                                                                              AIII                                                                                                                                                          OR =3.5 (1.6, 7.6), *P*\<0.05                                                                                                                                                                     OR =2.23 (1.42, 3.52), *P*\<0.001                                                                                                                                       U: +\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: +                                                                                                                                                                                                                                                                                                                                   

  Self-efficacy: confident in controlling future health                                                                                              AIII                                                                                                                                                          NS                                                                                                                                                                                                NS[‡‡](#tfn25-ppa-8-519){ref-type="table-fn"}                                                                                                                           U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

                                                                                                                                                     AIII                                                                                                                                                          NS                                                                                                                                                                                                NS[‡‡](#tfn25-ppa-8-519){ref-type="table-fn"}                                                                                                                           U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  **Diabetes (oral and/or parenteral anti-diabetics)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Venturini[@b80-ppa-8-519],[§§](#tfn26-ppa-8-519){ref-type="table-fn"}                                                                              USA; patients from HMO-providing health services, n=786                                                                                                       Adherence by record review (continuous measure corrected for self-reported baseline adherence), last time point flexible, but within 24 months                                                    Perception of mental health (mood state, SF-36)                                                                                                                         EI                                                  NR                                                                                                                                                                                                    NS                                                               U: NR\      2 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: 0        

  **Heart disease and hypertension (cardiovascular medication)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  Gazmararian[@b81-ppa-8-519],[\|\| \|\|](#tfn27-ppa-8-519){ref-type="table-fn"}                                                                     USA; community-dwelling patients, n=1,549                                                                                                                     Non-adherence by record review, 12 months                                                                                                                                                         Social support (instrument NR)                                                                                                                                          CIII                                                NS                                                                                                                                                                                                    NT                                                               U: 0\       3 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: NT       

  Nabi[@b82-ppa-8-519]                                                                                                                               Finland: local government employees, n=1,021                                                                                                                  Non-adherence by record review (ordinal measure), 12 months                                                                                                                                       Anxiety (ATS)                                                                                                                                                           EI                                                  NS                                                                                                                                                                                                    NT                                                               U: 0\       1 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: NT       

  Hostility (FTSSH)                                                                                                                                  D                                                                                                                                                             NS                                                                                                                                                                                                NT                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NT                                                                                                                                                                                                                                                                                                                                  

  Optimism (LOT-R)                                                                                                                                   D                                                                                                                                                             NS                                                                                                                                                                                                NT                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NT                                                                                                                                                                                                                                                                                                                                  

  Pessimism (LOT-R)                                                                                                                                  D                                                                                                                                                             NS                                                                                                                                                                                                NT                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NT                                                                                                                                                                                                                                                                                                                                  

  Psychological distress (GHQ)                                                                                                                       EI                                                                                                                                                            NS                                                                                                                                                                                                NT                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NT                                                                                                                                                                                                                                                                                                                                  

  Sense of coherence (SOC)                                                                                                                           D                                                                                                                                                             OR =0.62 (0.36, 1.05), *P*\<0.10                                                                                                                                                                  OR =0.55 (0.31, 0.96), *P*\<0.05                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: +                                                                                                                                                                                                                                                                                                                                   

  Grégoire[@b83-ppa-8-519]                                                                                                                           Canada: hypertensive adults with prescription from network of pharmacies, n=692                                                                               Non-adherence by self-report (Morisky Scale), 3 months                                                                                                                                            (Interview, self-developed items): beliefs concerning efficacy of antihypertensive medication                                                                           AI                                                  NS                                                                                                                                                                                                    NS                                                               U: 0\       0 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: 0        

  Beliefs concerning hypertension as risk factor for other diseases                                                                                  AII                                                                                                                                                           "No effect" versus "a lot of effect" (ref cat): OR =1.74 (1.08, 2.81), *P*=0.02                                                                                                                   "No effect" versus "a lot of effect": OR =2.00 (1.21, 3.33), *P*≤0.05                                                                                                   U: −\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: −                                                                                                                                                                                                                                                                                                                                   

  How much are you at risk of a heart attack because of your hypertension if you follow your doctor's advice?                                        AII                                                                                                                                                           NS                                                                                                                                                                                                NS                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  How much are you at risk of a stroke because of your hypertension if you follow your doctor's advice?                                              AII                                                                                                                                                           NS                                                                                                                                                                                                NS                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  How much are you at risk of heart attack because of your hypertension if you do not do anything about it?                                          AII                                                                                                                                                           "Do not know" versus "no to moderate risk" (ref cat): OR =0.46 (0.19, 1.12), *P*=0.09                                                                                                             NS                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  How much are you at risk of stroke because of your hypertension if you do not do anything about it?                                                AII                                                                                                                                                           "Do not know" versus "no to moderate risk" (ref cat): OR =0.44 (0.17, 1.16), *P*=0.10                                                                                                             "Do not know" versus "no to moderate risk": OR =0.40 (0.15, 1.09), *P*=0.07                                                                                             U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Social support (Pearlin et al[@b109-ppa-8-519])                                                                                                    CIII                                                                                                                                                          NS                                                                                                                                                                                                NS                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Miller[@b84-ppa-8-519],[§§§](#tfn32-ppa-8-519){ref-type="table-fn"}                                                                                Site not reported: patients from institutions providing cardiac rehabilitation programs, n=141                                                                Adherence by self-report (continuous measure, HBS), 6--9 months                                                                                                                                   Attitude towards medication taking (MAS)                                                                                                                                AI                                                  NR                                                                                                                                                                                                    NS                                                               U: NR\      0 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: 0        

  Beliefs about which steps of the medical regimen people most important to them think they should perform (HIS)                                     CII                                                                                                                                                                                                                                                                                                                                                             NS                                                                                                                                                                      U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Molloy[@b85-ppa-8-519],[§§§](#tfn32-ppa-8-519){ref-type="table-fn"}                                                                                UK; patients admitted to one of four London hospitals with Acute Coronary Syndrome, n=295                                                                     Adherence by self-report, 12 months                                                                                                                                                               Emotional support (derived from Berkman et al[@b110-ppa-8-519] and Seeman et al[@b111-ppa-8-519])                                                                       CIII                                                NS                                                                                                                                                                                                    NS                                                               U: 0\       1 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: 0        

  Practical support                                                                                                                                  CIII                                                                                                                                                          Number of patients providing practical support: 0: 39.7% adherent. 1: 40.5% adherent. Two or more: 59.2% adherent, *P*=0.004                                                                      OR =2.12 (1.06, 4.26), *P*=0.03                                                                                                                                         U: +\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: +                                                                                                                                                                                                                                                                                                                                   

  **HIV (antiretroviral medication)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Deschamps[@b86-ppa-8-519]                                                                                                                          Belgium; outpatients of university hospital, n=60                                                                                                             Non-adherence by MEMS, 5--6 months after measuring psychosocial constructs                                                                                                                        Anxiety (AMHI)                                                                                                                                                          EI                                                  NS                                                                                                                                                                                                    NR                                                               U: 0\       1 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: NR       

  Coping style: confrontational (AWC)                                                                                                                BI                                                                                                                                                            NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Coping style: distancing                                                                                                                           BII                                                                                                                                                           NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Coping style: self-controlling                                                                                                                     BII                                                                                                                                                           NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Coping style: seek social support                                                                                                                  CIII                                                                                                                                                          NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Coping style: accept responsibility                                                                                                                BII                                                                                                                                                           NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Coping style: escape-avoidance (higher score = more escape-avoidance)                                                                              BII                                                                                                                                                           Adherent patients 7.2, (2.2) versus non-adherent patients 10.1 (2.8), *P*=0.003                                                                                                                                                                                                                                                                                           U: −\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Coping style: planful problem solving (higher score = more planful problem solving)[\|\| \|\| \|\|](#tfn33-ppa-8-519){ref-type="table-fn"}         BI                                                                                                                                                            Adherent patients 7.5 (median), 3 (IQR) versus non-adherent patients 9 (median), 2 (IQR), *P*=0.049                                                                                                                                                                                                                                                                       U: −\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Coping style: positive reappraisal                                                                                                                 BI                                                                                                                                                            NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Depression (AMHI)                                                                                                                                  EI                                                                                                                                                            NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Perceived benefits of treatment (APIAQ)                                                                                                            AI                                                                                                                                                            Adherent patients 21 (3.5) versus non-adherent patients 18.7 (3.9), *P*=0.07                                                                                                                                                                                                                                                                                              U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Perceived severity of seriousness of implications when not taking medications adequately                                                           AI                                                                                                                                                            NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Perceived susceptibility of developing AIDS when not taking medications as prescribed                                                              AI                                                                                                                                                            NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Positive affect (eg, happiness person)                                                                                                             D                                                                                                                                                             NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Received social support (AGSRP)                                                                                                                    CIII                                                                                                                                                          NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Self-efficacy in taking HAART medication (ALTMBSES)                                                                                                AIII                                                                                                                                                          NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Holmes[@b87-ppa-8-519]                                                                                                                             USA; HIV-clinic patients, n=116                                                                                                                               Adherence by MEMS, 12 months (or when viral load of ≥1,000 copies/mL was reached)                                                                                                                 Depressive symptoms (CES-D)                                                                                                                                             EI                                                  High adherence 12.6 (11.3),\                                                                                                                                                                          NS                                                               U: 0\       2 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 low adherence 16.5 (11.7), *P*=0.06                                                                                                                                                                                                                                    M: 0        

  HIV-disclosure worries (HAT-QOL)                                                                                                                   AII                                                                                                                                                           NS                                                                                                                                                                                                NT                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NT                                                                                                                                                                                                                                                                                                                                  

  Health worries (higher score = fewer worries)                                                                                                      AII                                                                                                                                                           High adherence 79.2 (23.9),\                                                                                                                                                                      NS                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                   low adherence 70.4 (28.9), *P*=0.06                                                                                                                                                                                                                                                                                                                                       M: 0                                                                                                                                                                                                                                                                                                                                   

  Medication worries (higher score = fewer worries)                                                                                                  AI                                                                                                                                                            High adherence 86.1 (20.4),\                                                                                                                                                                      NS                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                   low adherence 83.3 (18.3), *P*=0.06                                                                                                                                                                                                                                                                                                                                       M: 0                                                                                                                                                                                                                                                                                                                                   

  Provider trust                                                                                                                                     CI                                                                                                                                                            NS                                                                                                                                                                                                NT                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NT                                                                                                                                                                                                                                                                                                                                  

  Social support (ISEL)                                                                                                                              CIII                                                                                                                                                          NS                                                                                                                                                                                                NT                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NT                                                                                                                                                                                                                                                                                                                                  

  Stress (PSS)                                                                                                                                       EII                                                                                                                                                           High adherence 12.4 (7.8),\                                                                                                                                                                       NS                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                   low adherence 15.3 (8.2), *P*=0.07                                                                                                                                                                                                                                                                                                                                        M: 0                                                                                                                                                                                                                                                                                                                                   

  Delgado[@b88-ppa-8-519]                                                                                                                            Canada; patients enrolled in community drug treatment program, n=316                                                                                          Adherence by record review, 12 months                                                                                                                                                             Depressive symptoms (CES-D)                                                                                                                                             EI                                                  Not reporting depression: 79.8% adherent, reporting depression: 68.1% adherent, *P*=0.02                                                                                                              NS                                                               U: −\       1 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: 0        

  Singh[@b89-ppa-8-519]                                                                                                                              USA; new veteran patients seen at medical center, n=52                                                                                                        Non-adherence by record review, 6 months                                                                                                                                                          Confusion and bewilderment (POMS)                                                                                                                                       BII                                                 NS                                                                                                                                                                                                    NT                                                               U: 0\       1 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: NT       

  Depression and dejection                                                                                                                           EI                                                                                                                                                            Adherent 14.2 (SEM 1.9), non-adherent 22.1 (SEM 3.4), *P*=0.04                                                                                                                                    NS                                                                                                                                                                      U: −\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Mood disturbance                                                                                                                                   EI                                                                                                                                                            39% in adherent patients, 76% in non-adherent patients, *P*=0.03                                                                                                                                  OR =1.4 (1.1, 1.8), *P*=0.01                                                                                                                                            U: −\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: −                                                                                                                                                                                                                                                                                                                                   

  Religious support (instrument NR)                                                                                                                  CIII                                                                                                                                                          NS                                                                                                                                                                                                NT                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NT                                                                                                                                                                                                                                                                                                                                  

  Social support (instrument NR)                                                                                                                     CIII                                                                                                                                                          NS                                                                                                                                                                                                NT                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NT                                                                                                                                                                                                                                                                                                                                  

  Symptoms of depression (BDI)                                                                                                                       EI                                                                                                                                                            NS                                                                                                                                                                                                NT                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NT                                                                                                                                                                                                                                                                                                                                  

  Tension and anxiety (POMS)                                                                                                                         EI                                                                                                                                                            NS                                                                                                                                                                                                NT                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NT                                                                                                                                                                                                                                                                                                                                  

  Singh[@b90-ppa-8-519]                                                                                                                              Site not reported: patients in HIV-medical centers, n=138                                                                                                     Non-adherence by record review, 6 months                                                                                                                                                          Coping style: active-behavioral focused (higher score = greater applicability of coping style to patient, BMICIS)                                                       BI                                                  (Mean score, SEM): non-adherent 5.2 (0.5) versus adherent 6.6 (0.2), *P*=0.01                                                                                                                         NR                                                               U: +\       1 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: NR       

  Coping style: active-cognitive focused                                                                                                             BI                                                                                                                                                            NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Coping style: avoidant coping                                                                                                                      BII                                                                                                                                                           Non-adherent 3.3 (0.3) versus adherent 2.6 (0.2), *P*=0.02                                                                                                                                                                                                                                                                                                                U: −\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Coping style: emotion-focused                                                                                                                      BII                                                                                                                                                           NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Coping style: problem-focused                                                                                                                      BI                                                                                                                                                            Non-adherent 6.0 (0.5) versus adherent 7.1 (0.2), *P*=0.02                                                                                                                                                                                                                                                                                                                U: +\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Hopelessness: future expectations                                                                                                                  BII                                                                                                                                                           NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Hopelessness: loss of motivation (higher score = more hopelessness, BHS)                                                                           BII                                                                                                                                                           Non-adherent 1.75 (0.5), adherent 0.6 (0.1), *P*=0.006                                                                                                                                                                                                                                                                                                                    U: −\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Hopelessness: negative feelings about future                                                                                                       BII                                                                                                                                                           NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Hopelessness: total score                                                                                                                          BII                                                                                                                                                           NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Quality of life: psychological functioning (MOS SF-36)                                                                                             EI                                                                                                                                                            NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Satisfaction with social support: emotional (SSQ)                                                                                                  CIII                                                                                                                                                          NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Satisfaction with social support: informational (higher scores = less satisfaction)                                                                CIII                                                                                                                                                          Non-adherent 7.9 (1.1), adherent 6.1 (0.3), *P*=0.04                                                                                                                                                                                                                                                                                                                      U: +\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Satisfaction with social support: tangible                                                                                                         CIII                                                                                                                                                          Non-adherent 7.7 (1.1), adherent 5.5 (0.3), *P*=0.07                                                                                                                                                                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Satisfaction with social support: total score                                                                                                      CIII                                                                                                                                                          Non-adherent 22.9 (3.3), adherent 16.8 (0.75), *P*=0.03                                                                                                                                                                                                                                                                                                                   U: +\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Bottonari[@b91-ppa-8-519]                                                                                                                          USA; patients treated in immunodeficiency clinic, n=78                                                                                                        Adherence by self-report (straightforward), 6--9 months                                                                                                                                           Depressive symptoms (IDD)                                                                                                                                               EI                                                  NS                                                                                                                                                                                                    NR                                                               U: 0\       0 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: NR       

  Experience of general (stressful) life events (LES)                                                                                                EII                                                                                                                                                           NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  HIV-specific (stressful) life events (BHLES)                                                                                                       EII                                                                                                                                                           NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Neuroticism: personality style indicative of affective instability (NSEPQSS)                                                                       D                                                                                                                                                             NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Perceived stress (PSS)                                                                                                                             EII                                                                                                                                                           OR =0.88 (0.77, 0.98), *P*=0.04                                                                                                                                                                                                                                                                                                                                           U: −\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Self-esteem (RSEQR)                                                                                                                                D                                                                                                                                                             NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Godin[@b92-ppa-8-519]                                                                                                                              Canada; patients from medical HIV-clinics, n=400                                                                                                              Adherence over time by self-report (straightforward), 12 months                                                                                                                                   Change in predictors related to adherence over time: attitude towards medication-taking (more positive attitude = greater adherence, self-developed scale)              AI                                                  NR                                                                                                                                                                                                    OR =1.56 (1.18, 2.06), *P*≤0.05                                  U: NR\      1 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: +        

  Optimism (DOS)                                                                                                                                     D                                                                                                                                                                                                                                                                                                                                                               NS                                                                                                                                                                      U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Outcome expectations (eg, believe that specific course of action will lead to desired outcome, self-developed scale)                               AIII                                                                                                                                                                                                                                                                                                                                                            NS                                                                                                                                                                      U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Patient-doctor satisfaction (Pat SS)                                                                                                               CI                                                                                                                                                                                                                                                                                                                                                              NS                                                                                                                                                                      U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Self-efficacy regarding medication taking (self-developed scale)                                                                                   AIII                                                                                                                                                                                                                                                                                                                                                            OR =1.68 (1.27, 2.22), *P*≤0.05                                                                                                                                         U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: +                                                                                                                                                                                                                                                                                                                                   

  Social support (SPS)                                                                                                                               CIII                                                                                                                                                                                                                                                                                                                                                            NS                                                                                                                                                                      U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Kacanek[@b93-ppa-8-519]                                                                                                                            USA; patients recruited by media and physician networks, n=225                                                                                                Suboptimal adherence by self-report (straightforward): max 30 months                                                                                                                              Development of depressive symptoms (BST)                                                                                                                                EI                                                  Suboptimal adherence in those who developed depressive symptoms =45.1% versus 25.9% in those with no depressive symptoms, *P*=0.01                                                                    NT                                                               U: −\       2 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: NT       

  Martini[@b94-ppa-8-519],[§§§](#tfn32-ppa-8-519){ref-type="table-fn"}                                                                               Italy; outpatients using combination therapy, n=214                                                                                                           Adherence by self-report (ordinal measure, straightforward questionnaire), 12 months                                                                                                              (Interview, instrument NR): perception of therapy: reliable?                                                                                                            AI                                                  In "high adherence" category, therapy perceived as "reliable" by 15.6%, and "not reliable" by 84.4%. In "variable adherence" cat 4.8% versus 95.2%. In "low adherence" cat 0% versus 100%, *P*=0.02   NR                                                               U: +\       0 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: NR       

  Perception of therapy: enslaving?                                                                                                                  AI                                                                                                                                                            NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Satisfied about doctor/patient discussion regarding clinical and therapeutic aspects of treatment?                                                 CI                                                                                                                                                            In "high adherence" category: "sufficient/highly satisfied" = 73.9%, "little/not satisfied" =26.1%. In "variable adherence" cat 80% versus 20%. in "low adherence" cat 50% versus 50%, *P*=0.05                                                                                                                                                                           U: ?\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Mellins[@b95-ppa-8-519]                                                                                                                            USA; HIV-infected mothers recruited in waiting room of adult clinic, n=128                                                                                    Non-adherence by self-report (AACTG, straightforward), T1 after 4--5 months, T2 8--18 months after T1                                                                                             Negative stressful events (PEI)                                                                                                                                         EII                                                 OR =1.27 (1.09, 1.49), *P*\<0.01 at T1, OR =1.28 (1.05, 1.57), *P*=0.02 at T2                                                                                                                         NR                                                               U: −\       0 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: NR       

  Parenting stress (low scores = more stress, PPCS)                                                                                                  EII                                                                                                                                                           OR =0.86 (0.76, 0.98), *P*=0.02 at T2                                                                                                                                                                                                                                                                                                                                     U: −\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Psychological distress (aggregated demoralization score, DSPERI)                                                                                   EI                                                                                                                                                            NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Self-efficacy in carrying out health-related behaviors (Chesney et al[@b112-ppa-8-519])                                                            AIII                                                                                                                                                          NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Nilsson Schönnesson[@b96-ppa-8-519]                                                                                                                Sweden; patients recruited by clinic nurses, n=203                                                                                                            Adherence by self-report (straightforward), 24 months                                                                                                                                             Anxiety symptoms (ASBSI)                                                                                                                                                EI                                                  NR                                                                                                                                                                                                    NS                                                               U: NR\      1 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: 0        

  Belief in adherence necessity (one item)                                                                                                           AI                                                                                                                                                                                                                                                                                                                                                              NS                                                                                                                                                                      U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Belief that ART prolongs one's life (one item)                                                                                                     AI                                                                                                                                                                                                                                                                                                                                                              NS                                                                                                                                                                      U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Belief in future HIV-related health problems (self-developed scale)                                                                                AII                                                                                                                                                                                                                                                                                                                                                             NS                                                                                                                                                                      U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Belief in influencing HIV disease (MAH)                                                                                                            AII                                                                                                                                                                                                                                                                                                                                                             NS                                                                                                                                                                      U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Beliefs in ART health concerns (eg, believe that medication makes sicker, one item)                                                                AI                                                                                                                                                                                                                                                                                                                                                              NS                                                                                                                                                                      U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Coping mode: helplessness (MAH)                                                                                                                    BII                                                                                                                                                                                                                                                                                                                                                             NS                                                                                                                                                                      U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Coping mode: resilience (MAH)                                                                                                                      D                                                                                                                                                                                                                                                                                                                                                               NS                                                                                                                                                                      U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Depressive symptoms (DSBSI)                                                                                                                        EI                                                                                                                                                                                                                                                                                                                                                              NS                                                                                                                                                                      U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Global social support satisfaction (one item)                                                                                                      CIII                                                                                                                                                                                                                                                                                                                                                            NS                                                                                                                                                                      U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Hopelessness (BHS)                                                                                                                                 BII                                                                                                                                                                                                                                                                                                                                                             NS                                                                                                                                                                      U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Life stress (LSS)                                                                                                                                  EII                                                                                                                                                                                                                                                                                                                                                             NS                                                                                                                                                                      U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Patient-provider relationship (self-developed scale)                                                                                               CI                                                                                                                                                                                                                                                                                                                                                              NS                                                                                                                                                                      U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Perceived pressure to take HIV medication (self-developed scale)                                                                                   CIII                                                                                                                                                                                                                                                                                                                                                            NS                                                                                                                                                                      U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Posttraumatic stress disorder symptoms related to HIV diagnosis (HIE)                                                                              EI                                                                                                                                                                                                                                                                                                                                                              NS                                                                                                                                                                      U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Self-efficacy in taking medication (self-developed scale)                                                                                          AIII                                                                                                                                                                                                                                                                                                                                                            NS                                                                                                                                                                      U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Thrasher[@b97-ppa-8-519]                                                                                                                           USA; patients in public use of HCSUS data-set, n=1,911                                                                                                        Adherence by self-report (straightforward),12 months                                                                                                                                              (Instruments NR): depressive symptoms                                                                                                                                   EI                                                  OR =0.98 (0.96, 0.99), *P*=0.007                                                                                                                                                                      NR                                                               U: −\       1 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: NR       

  Dysthymia symptoms                                                                                                                                 EI                                                                                                                                                            OR =0.92 (0.87, 0.96), *P*=0.001                                                                                                                                                                                                                                                                                                                                          U: −\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Social support                                                                                                                                     CIII                                                                                                                                                          NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Horne[@b98-ppa-8-519]                                                                                                                              UK; outpatients, eligible to receive HAART, n=136                                                                                                             Adherence by self-report (VAS-scale from MASRI, straightforward), 12 months                                                                                                                       Depressive symptoms (HADS)                                                                                                                                              EI                                                  NS                                                                                                                                                                                                    NT                                                               U: 0\       3 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: NT       

  HAART concern beliefs about medication (BMQ)                                                                                                       AI                                                                                                                                                            High adherence 2.9 (0.6) versus low adherence 3.3 (0.6), *P*=0.005                                                                                                                                OR =0.45 (0.22, 0.96), *P*=0.038                                                                                                                                        U: −\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: −                                                                                                                                                                                                                                                                                                                                   

  HAART necessity beliefs about medication                                                                                                           AI                                                                                                                                                            High adherence 4.0 (0.6) versus low adherence 3.7 (0.6), *P*=0.006                                                                                                                                OR =2.19 (1.02, 4.71), *P*=0.045                                                                                                                                        U: +\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: +                                                                                                                                                                                                                                                                                                                                   

  Mugavero[@b99-ppa-8-519]                                                                                                                           USA; patients receiving care at one of eight infectious disease clinics, n=474                                                                                Non-adherence by self-report (AACTG, straightforward, corrected for baseline non-adherence), 27 months                                                                                            Number of severe stressful events (LES, modified version)                                                                                                               EII                                                 OR (per event) =1.14 (1.03, 1.26)                                                                                                                                                                     NS                                                               U: −\       3 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: 0        

  Number of stressful events (moderate + severe stressful events)                                                                                    EII                                                                                                                                                           OR (per event) =1.09 (1.04, 1.13)                                                                                                                                                                 OR (per event) =1.10 (1.04, 1.16)                                                                                                                                       U: −\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: −                                                                                                                                                                                                                                                                                                                                   

  Number of traumatic events                                                                                                                         EII                                                                                                                                                           OR (per event) =1.73 (1.24, 2.39)                                                                                                                                                                 NS                                                                                                                                                                      U: −\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Number of types of lifetime traumatic experiences (composite measure of diverse questionnaires)                                                    EII                                                                                                                                                           NS                                                                                                                                                                                                NS                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Carrieri[@b100-ppa-8-519]                                                                                                                          France; patients starting HAART-regimen including at least oneprotease inhibitor, n=1,110                                                                     Non-adherence by self-report (AACTG,straightforward), 60 months                                                                                                                                   Depressive symptoms (CES-D)                                                                                                                                             EI                                                  b =0.22 (95% CI =0.12, 0.32), *P*\<0.001                                                                                                                                                              b =0.18 (0.07, 0.29)                                             U: −\       2 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: −        

  Support from partner (whether principal or not, instrument NR)                                                                                     CII                                                                                                                                                           b =−0.16 (−0.26, −0.07), *P*=0.001                                                                                                                                                                b =−0.15 (−0.25, −0.05)                                                                                                                                                 U: +\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: +                                                                                                                                                                                                                                                                                                                                   

  **Transplant-related (immunosuppressant medication)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Stilley[@b101-ppa-8-519]                                                                                                                           USA; transplant patients, recruited before hospital discharge or atearly clinic visit, n=152                                                                  Adherence by MEMS (continuous measure), 6 months                                                                                                                                                  Affective dysregulation (degree of negative affectivity and irritability, DI)                                                                                           EI                                                  Correlation coefficient: NS[¶¶](#tfn28-ppa-8-519){ref-type="table-fn"}                                                                                                                                NR                                                               U: 0\       1 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: NR       

  Behavioral dysregulation (impulsivity, sensation seeking, aggression)                                                                              D                                                                                                                                                             r=0.26, *P*≤0.05[\*\*\*](#tfn29-ppa-8-519){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                           U: −[†††](#tfn30-ppa-8-519){ref-type="table-fn"}\                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Cognitive dysregulation (less strategic thinking, problem solving, self-monitoring)                                                                BI                                                                                                                                                            NS[¶¶](#tfn28-ppa-8-519){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                                             U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Family environment (family support, FRI)                                                                                                           CII                                                                                                                                                           NS[¶¶](#tfn28-ppa-8-519){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                                             U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Hostility (CMHS)                                                                                                                                   D                                                                                                                                                             NS[¶¶](#tfn28-ppa-8-519){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                                             U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  De Geest[@b102-ppa-8-519]                                                                                                                          Belgium; convenience sample of outpatients, n=101                                                                                                             Non-adherence by MEMS (ordinal measure, correction for past adherence), 6 months                                                                                                                  Depressive symptoms (BDI)                                                                                                                                               EI                                                  NR                                                                                                                                                                                                    NS                                                               U: NR\      2 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: 0        

  Self-efficacy in taking medication (LTMSES)                                                                                                        AIII                                                                                                                                                                                                                                                                                                                                                            Median =4.85 (Q1 =4.70, Q3 =5.00) for excellent adherers, 4.81 (Q1 =4.70, Q3 =4.89) for moderate non-adherers, 4.41 (Q1 =4.30, Q3 =4.81) for minor adherers, *P*=0.04   U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: +                                                                                                                                                                                                                                                                                                                                   

  Social support (PRQ)                                                                                                                               CIII                                                                                                                                                                                                                                                                                                                                                            NS                                                                                                                                                                      U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Symptom distress (ATSFDS)                                                                                                                          EII                                                                                                                                                                                                                                                                                                                                                             NS                                                                                                                                                                      U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Russell[@b103-ppa-8-519]                                                                                                                           USA; convenience sample of renal transplant patients, n=50                                                                                                    Adherence by MEMS (ordinal measure), 12 months                                                                                                                                                    Depressive symptoms (BDI)                                                                                                                                               EI                                                  NS                                                                                                                                                                                                    NR                                                               U: 0\       0 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: NR       

  Emotional burden (MS)                                                                                                                              EI                                                                                                                                                            NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Self-efficacy in taking medication (LTMSES)                                                                                                        AIII                                                                                                                                                          NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Social support (SSAI)                                                                                                                              CIII                                                                                                                                                          NS                                                                                                                                                                                                                                                                                                                                                                        U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NR                                                                                                                                                                                                                                                                                                                                  

  Weng[@b104-ppa-8-519]                                                                                                                              USA; patients recruited at time of renal transplantation, n=829                                                                                               Adherence by MEMS (ordinal measure), 12 months posttransplantation                                                                                                                                Beliefs regarding who or what controls and influences one's health (MHLCS)                                                                                              AIII                                                OR =1.05 (1.00, 1.11), *P*=0.05 (powerful others subscale)                                                                                                                                            NS                                                               U: +\       2 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: 0        

  Depressive symptoms (CES-D)                                                                                                                        EI                                                                                                                                                            NS                                                                                                                                                                                                NT                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NT                                                                                                                                                                                                                                                                                                                                  

  Perceived stressfulness of transplant-related issues (TSQ)                                                                                         EII                                                                                                                                                           NS                                                                                                                                                                                                NT                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NT                                                                                                                                                                                                                                                                                                                                  

  Perceptions that social needs are being met (friends and family sub-score, SSAS)                                                                   CII                                                                                                                                                           NS                                                                                                                                                                                                NT                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NT                                                                                                                                                                                                                                                                                                                                  

  Dew[@b105-ppa-8-519]                                                                                                                               USA; heart transplant patients at academic hospital[‡‡‡](#tfn31-ppa-8-519){ref-type="table-fn"}, n=108                                                        Non-adherence by self-report (straight-forward), 12 months post-transplantation                                                                                                                   Coping strategies: use of active-behavioral coping (Coping checklist)                                                                                                   BI                                                  NS                                                                                                                                                                                                    NT                                                               U: 0\       2 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: NT       

  Coping strategies: use of active-cognitive coping                                                                                                  BI                                                                                                                                                            NS                                                                                                                                                                                                NT                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NT                                                                                                                                                                                                                                                                                                                                  

  Coping strategies: use of avoidance coping (% high)                                                                                                BII                                                                                                                                                           Non-adherent 58.8%, adherent 29.9%, *P*\<0.05                                                                                                                                                     OR =9.71, *P*\<0.05                                                                                                                                                     U: −\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: −                                                                                                                                                                                                                                                                                                                                   

  Emotional status: anger-hostility symptoms (SCL-90)                                                                                                EI                                                                                                                                                            Non-adherent 47.1%, adherent 12.1%, *P*\<0.001                                                                                                                                                    OR =13.40, *P*\<0.05                                                                                                                                                    U: −\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: −                                                                                                                                                                                                                                                                                                                                   

  Emotional status: anxiety symptoms                                                                                                                 EI                                                                                                                                                            Non-adherent 82.4%, adherent 53%, *P*\<0.05                                                                                                                                                       NS                                                                                                                                                                      U: −\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Emotional status: depressive symptoms                                                                                                              EI                                                                                                                                                            NS                                                                                                                                                                                                NT                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NT                                                                                                                                                                                                                                                                                                                                  

  Sense of mastery (ie, control over life, SMS)                                                                                                      AIII                                                                                                                                                          NS                                                                                                                                                                                                NT                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NT                                                                                                                                                                                                                                                                                                                                  

  Social support: caregiver support (% poor) (Spanier,[@b113-ppa-8-519] Pearlin and Schooler)[@b114-ppa-8-519]                                       CII                                                                                                                                                           Non-adherent 52.9%, adherent 27.0%, *P*\<0.05                                                                                                                                                     NS                                                                                                                                                                      U: −\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Social support: friend support (Moos)[@b115-ppa-8-519]                                                                                             CII                                                                                                                                                           NS                                                                                                                                                                                                NT                                                                                                                                                                      U: 0\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: NT                                                                                                                                                                                                                                                                                                                                  

  Dew[@b106-ppa-8-519]                                                                                                                               USA; patients receiving first lung transplantation in academic hospital, n=178                                                                                Non-adherence by self-report (straightforward), 24 months                                                                                                                                         Anger-hostility symptoms (SC)                                                                                                                                           EI                                                  (Correlation coefficient, significant if r≥0.15[\*\*\*](#tfn29-ppa-8-519){ref-type="table-fn"}): r≥0.15                                                                                               NS                                                               U: ?\       1 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: 0        

  Anxiety symptoms (SC)                                                                                                                              EI                                                                                                                                                            r≥0.15                                                                                                                                                                                            NS                                                                                                                                                                      U: ?\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Care provider locus of control (health outcomes due to professional? MHLCS)                                                                        AIII                                                                                                                                                          r≥0.15                                                                                                                                                                                            NS                                                                                                                                                                      U: ?\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Chance locus of control (health outcomes occur by chance?)                                                                                         AIII                                                                                                                                                          r≥0.15                                                                                                                                                                                            NS                                                                                                                                                                      U: ?\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Degree to which one can rely on friends for emotional/practical support/friend support (Moos)[@b115-ppa-8-519]                                     CII                                                                                                                                                           r≥0.15                                                                                                                                                                                            NS                                                                                                                                                                      U: ?\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Depressive symptoms (SC)                                                                                                                           EI                                                                                                                                                            r≥0.15                                                                                                                                                                                            NS                                                                                                                                                                      U: ?\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Expectations about the future/optimism (LOT)                                                                                                       D                                                                                                                                                             r≥0.15                                                                                                                                                                                            NS                                                                                                                                                                      U: ?\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Internal locus of control (can I influence my health outcome? MHLCS)                                                                               AIII                                                                                                                                                          r≥0.15                                                                                                                                                                                            NS                                                                                                                                                                      U: ?\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Supportiveness (both emotionally and practically) of recipient's relationship with their primary family caregiver (when low = higher odds) (DAS)   CII                                                                                                                                                           r≥0.15                                                                                                                                                                                            OR =2.59 (1.20, 5.58), *P*\<0.05                                                                                                                                        U: ?\                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: −                                                                                                                                                                                                                                                                                                                                   

  Dobbels[@b107-ppa-8-519]                                                                                                                           Belgium: heart, liver and lung transplant patients listed at university hospitals, n=186                                                                      Non-adherence by self-report (straightforward, corrected for pre-transplant adherence), 12 months posttransplantation                                                                             Agreeableness (one's orientation along continuum from compassion to antagonism, NEO-FFI)                                                                                D                                                   NR                                                                                                                                                                                                    NT or NS                                                         U: NR/NS\   1 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: 0        

  Anxiety symptoms (HADS)                                                                                                                            EI                                                                                                                                                                                                                                                                                                                                                              NT or NS                                                                                                                                                                U: NR/NS\                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Conscientiousness (ie, degree of organization, NEO-FFI)                                                                                            D                                                                                                                                                                                                                                                                                                                                                               OR =0.80 (0.67, 0.95), *P*=0.01                                                                                                                                         U: NR/NS\                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: +                                                                                                                                                                                                                                                                                                                                   

  Depressive symptoms (HADS)                                                                                                                         EI                                                                                                                                                                                                                                                                                                                                                              NT or NS                                                                                                                                                                U: NR/NS\                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Extraversion (capacity for joy, need for stimulation, NEO-FFI)                                                                                     D                                                                                                                                                                                                                                                                                                                                                               NT or NS                                                                                                                                                                U: NR/NS\                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  General received practical and informational support (SSQ)                                                                                         CIII                                                                                                                                                                                                                                                                                                                                                            NT or NS                                                                                                                                                                U: NR/NS\                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Neuroticism (NEO-FFI)                                                                                                                              D                                                                                                                                                                                                                                                                                                                                                               NT or NS                                                                                                                                                                U: NR/NS\                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Openness to experience (toleration for and exploration of the unfamiliar, NEO-FFI)                                                                 D                                                                                                                                                                                                                                                                                                                                                               NT or NS                                                                                                                                                                U: NR/NS\                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Received specific support with medication taking (SSQ)                                                                                             CIII                                                                                                                                                                                                                                                                                                                                                            OR =0.94 (0.89, 0.99), *P*=0.03                                                                                                                                         U: NR/NS\                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: +                                                                                                                                                                                                                                                                                                                                   

  DiMatteo[@b108-ppa-8-519],[\|\| \|\|](#tfn27-ppa-8-519){ref-type="table-fn"}                                                                       USA: patients from five medical specialties in HMOs, large multispecialty groups or solo practices, n=max 1,828[§§§](#tfn32-ppa-8-519){ref-type="table-fn"}   Adherence by self-report (straightforward, continuous measure, correction for baseline adherence), 24 months                                                                                      Health distress (instrument NR)                                                                                                                                         EII                                                 NR                                                                                                                                                                                                    ß =−0.22, *P*=0.05                                               U: NR\      0 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        M: −        

  Perceptions of physician's authoritativeness (self-developed scale)                                                                                CI                                                                                                                                                                                                                                                                                                                                                              NT or NS                                                                                                                                                                U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Satisfaction with interpersonal medical care (Sherbourne)[@b116-ppa-8-519]                                                                         CI                                                                                                                                                                                                                                                                                                                                                              NT or NS                                                                                                                                                                U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Social support (composite measure, Sherbourne and Stewart)[@b117-ppa-8-519]                                                                        CIII                                                                                                                                                                                                                                                                                                                                                            NT or NS                                                                                                                                                                U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   

  Tendency to use avoidance coping (instrument NR)                                                                                                   BII                                                                                                                                                                                                                                                                                                                                                             NT or NS                                                                                                                                                                U: NR\                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             M: 0                                                                                                                                                                                                                                                                                                                                   
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

NS (non significant): as reported in the concerning study. UD (undetermined): because of inadequate description in the concerning study.

Binary outcome measure, unless indicated otherwise. With a straightforward question, we mean that participants were directly asked to indicate how many medication doses they missed. For example: "How many pills did you take this week?";

follow-up period = number of months between baseline (unless indicated otherwise) and last adherence measurement;

if no instrument is mentioned for predictor, then previous mentioned instrument is applicable;

psychosocial category, to which a predictor was assigned. A = Beliefs and cognitions about: I) medication and treatment; II) illness; III) self-efficacy and locus of control. B = coping styles: I) task oriented, II) emotion oriented. C = Social influences and social support: I) regarding medical caregiver; II) regarding friends and family; III) in general. D = personality traits. E = psychological well-being: I) mood state; II) perceived stress/stressors;

OR: Odds Ratio (95% confidence interval). OR **\<**1 = lower chance of being adherent or non-adherent (for direction in relevant study, see column "Adherence, follow-up period") when predictor increases or when predictor ≠ reference category. OR \> 1 = greater change of being adherent or non-adherent when predictor increases (or when predictor ≠ reference category). Scores other than OR are the mean predictor scores with standard deviation, unless indicated otherwise;

\+ = higher level of predictor implies higher adherence at level *P*≤0.05; − = higher level of predictor implies less adherence at *P*≤0.05; 0 = no significant association between predictor and adherence at *P*≤0.05; ? = association present, but direction unclear;

to determine methodological quality, six bias domains per study were judged. Here, the total amount of bias free domains is reported (for further details, see table S3);

assumed that all variables, tested by univariate analysis, were also tested by multivariate analysis;

retrospective design;

Diagnosis for coronary heart disease, hypertension, diabetes mellitus and/or hyperlipidaemia;

not reported in study is interpreted by HZ/BvdB as not significant;

significance of *P*≤0.05 assumed by HZ/BvdB;

negative association assumed;

type of medication is immunosuppressants, antihypertensives, and/or antivirals;

use of chronic preventive medication assumed;

unexpected direction.

**Abbreviations:** AACTG, adult AIDS clinical trials group; ALTMBSES, adapted long term medication behavior self efficacy scale; AGSRP, adapted gay service research project; AIDS, acquired immunodeficiency syndrome; AMHI, adapted mental health inventory; APIAQ, adapted protease inhibitor attitude questionnaire; ART, antiretroviral therapy; ASBSI, anxiety subscale of brief symptom inventory; ATS, anxiety trait scale; ATSFDS, adapted version of transplant symptom frequency and distress scale; AWC, adapted ways of coping BDI, beck depression inventory; BHLES, buffalo HIV life events survey; BHS, beck hopelessness scale; BMICIS, Billings and Moos inventory of coping with illness styles; BMQ, beliefs about medication questionnaire; BST, Burnam interviewer-administered 8-item screening tool; CES-D, center for epidemiologic studies depression scale; CMHS, Cook-Medley hostility scale; DAS, dyadic adjustment scale; DI, dysregulation inventory; DOS, dispositional optimism scale; DSBSI, depression subscale of brief symptom inventory; DSPERI, demoralization scale of psychiatric epidemiology research interview; FRI, family relations index (from family environment scale); FTSSH, Finnish twin study scale of hostility; GHQ, general health questionnaire; HAART, highly active antiretroviral therapy; HADS, hospital anxiety and depression scale; HAT-QOL, HIV/AIDS-targeted quality of life instrument; HBS, health behaviour scale; HCSUS, HIV cost and services utilization study; HIE, Horowitz impact of events scale; HIS, health intention scale; HIV, human immunodeficiency virus; HMO, health maintenance organization; ICS, inhaled corticosteroids; IDD, inventory to diagnose depression; IQR, interquartile range; ISEL, interpersonal support evaluation list; LES, life experience survey; LOT-R, life orientation test; LSS, life stressors scale; LTMSES, long term medication self-efficacy scale; MAH, mental adjustment to HIV; MARS, medication adherence report scale; MAS, Miller attitude scale; MASRI, medication adherence self-report inventory; MEMS, medication even monitoring system; MHLCS, multidimensional health locus of control scale; MOS, medical outcome study health survey; MS, Memphis survey; NEO-FFI, NEO five factor inventory; NR, not reported; NS, non-significant; NSEPQSS, neuroticism scale of the Eysenck personality questionnaire-revised short scale; NT, not tested; OR, odds ratio; Pat SS, patient satisfaction scale; PEI, psychiatric epidemiology interview; POMS, profiles of mood states; PPCS, perceived parenting competence scale; PRQ, personal resource questionnaire; PSS, perceived stress scale; RSEQR, Rosenberg self-esteem questionnaire; SC, symptom checklist; SCL-90, Symptom Checklist-90-R; SEM, standard error of the mean; SF-36, short form-36 health survey; SMS, sense of mastery scale; SOC, sense of coherence; SPS, social provision scale; SSAI, social support appraisals index; SSAS, social support appraisal scale; SSQ, social support questionnaire; TSQ, transplant stress questionnaire; VAS, visual analog scale.

###### 

Results of judging methodologic quality

  First author                          Overall quality   Domain free of bias?                                       
  ------------------------------------- ----------------- ---------------------- -------- -------- -------- -------- --------
  Bottonari[@b91-ppa-8-519]             Low               No                     No       Partly   Partly   No       No
  De Geest[@b102-ppa-8-519]             Low               No                     Yes      Partly   Yes      No       Partly
  Delgado[@b88-ppa-8-519]               Low               Partly                 Yes      Partly   Partly   Partly   Partly
  Deschamps[@b86-ppa-8-519]             Low               No                     Partly   No       Yes      No       No
  Dew[@b105-ppa-8-519]                  Low               No                     Yes      Yes      Partly   Partly   Partly
  Dew[@b106-ppa-8-519]                  Low               Yes                    Partly   Partly   Partly   Partly   Partly
  DiMatteo[@b108-ppa-8-519]             Low               Partly                 No       Partly   No       No       No
  Dobbels[@b107-ppa-8-519]              Low               Yes                    Partly   Partly   Partly   Partly   No
  Gazmararian[@b81-ppa-8-519]           Low               Yes                    Partly   Partly   Yes      Partly   Yes
  Godin[@b92-ppa-8-519]                 Low               Partly                 Yes      No       Partly   Partly   Partly
  Grégoire[@b83-ppa-8-519]              Low               Partly                 No       No       Partly   No       Partly
  Holmes[@b87-ppa-8-519]                Low               Partly                 Yes      Partly   Partly   Partly   Yes
  Kacanek[@b93-ppa-8-519]               Low               No                     Yes      Partly   Partly   No       Yes
  Martini[@b94-ppa-8-519]               Low               Partly                 No       No       Partly   No       No
  Mellins[@b95-ppa-8-519]               Low               Partly                 Partly   Partly   No       No       No
  Miller[@b84-ppa-8-519]                Low               No                     Partly   Partly   No       Partly   Partly
  Nabi[@b82-ppa-8-519]                  Low               Partly                 Partly   Partly   Partly   Partly   Yes
  Nilsson Schönnesson[@b96-ppa-8-519]   Low               Partly                 Yes      Partly   No       Partly   No
  Ponieman[@b79-ppa-8-519]              Low               No                     No       Partly   Partly   Partly   Partly
  Russell[@b103-ppa-8-519]              Low               No                     No       Partly   Partly   No       Partly
  Singh[@b89-ppa-8-519]                 Low               No                     Yes      Partly   Partly   Partly   No
  Singh[@b90-ppa-8-519]                 Low               Partly                 Yes      Partly   Partly   No       No
  Stilley[@b101-ppa-8-519]              Low               Yes                    Partly   Partly   No       No       No
  Thrasher[@b97-ppa-8-519]              Low               Yes                    Partly   Partly   Partly   Partly   Partly
  Venturini[@b80-ppa-8-519]             Low               Yes                    Partly   Partly   Yes      Partly   Partly
  Weng[@b104-ppa-8-519]                 Low               Partly                 No       Yes      Partly   Partly   Yes
  Molloy[@b85-ppa-8-519]                Low               No                     Yes      Partly   No       Partly   Partly
  Horne[@b98-ppa-8-519]                 Low               Yes                    Yes      Partly   Partly   No       Yes
  Mugavero[@b99-ppa-8-519]              Low               Yes                    No       Yes      Partly   Partly   Yes
  Carrieri[@b100-ppa-8-519]             Low               No                     Yes      No       Partly   Partly   Yes

###### 

Sensitivity analyses: methodological quality, disease, adherence measures, and statistical analyses

  Alteration                                                                                                                           Relevant studies                                                                                        Categories affected                Change in level of evidence
  ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------- ---------------------------------- ---------------------------------------------------------
  **Alterations in methodological quality cut-offs**                                                                                                                                                                                                                              
  High-quality study when all six bias domains judged at least as partly (and no no-judgment) instead of ≥four domains judged as yes   19,26,34,35,42,52,64 now high-quality, all other studies low-quality                                    AI, II, III and CI, II and EII     No association: moderate instead of limited evidence
  CIII and EI                                                                                                                          No association: strong instead of limited evidence                                                                                         
  Low-quality study when ≥four domains judged as no instead of \<four domains judged as yes                                            19,26,33--36,38,39,42--44,46,47,49,51--60,64,65 now high-quality, all other studies still low-quality   All categories                     No association: strong instead of limited evidence
  **Alterations in disease**                                                                                                                                                                                                                                                      
  Only focus on HIV disease                                                                                                            19,25,42--49,51--55 (studies in analysis)                                                               AI                                 No association: conflicting instead of limited evidence
  CII and D                                                                                                                            Level undetermined (≤one study available)                                                                                                  
  Only focus on transplant-related diseases                                                                                            56--60,64,65 (studies in analysis)                                                                      AI, II, BII and CI                 Level undetermined (≤one study available)
  Focus on asthma, diabetes, heart disease/hypertension                                                                                26,33--36,38,39,66 (studies in analysis)                                                                AII, III, BI, II, CI, II, D, EII   Level undetermined (≤one study available)
  **Alterations in adherence measures**                                                                                                                                                                                                                                           
  Focus on objective adherence measures (MEMS, record review)                                                                          19,25,26,34,35,42--44,56--59 (studies in analysis)                                                      D                                  No association: conflicting instead of limited evidence
  AII and CI                                                                                                                           Level undetermined (≤one study available)                                                                                                  
  Focus on subjective adherence measures (self-report)                                                                                 33,36,38,39,45--49,51--55,60,64--66 (studies in analysis)                                               AI                                 No association: conflicting instead of limited evidence
  BI                                                                                                                                   Level of evidence undetermined (≤one study available)                                                                                      
  BII and EI                                                                                                                           No association: conflicting instead of limited evidence                                                                                    
  **Alterations in statistical analysis**                                                                                                                                                                                                                                         
  Only focus on univariate analysis instead of multivariate analysis                                                                   34,38,46,51,57,65,66 (studies omitted due to lack of univariate analysis)                               AI, AIII, CI, CIII, EI and EII     No association: conflicting instead of limited evidence

**Notes:** A = Beliefs and cognitions about: I) medication and treatment; II) illness; III) self-efficacy and locus of control. B = coping styles: I) task oriented, II) emotion oriented. C = Social influences and social support: I) regarding medical caregiver; II) regarding friends and family; III) in general. D = personality traits. E = psychological well-being: I) mood state; II) perceived stress/stressors.

**Abbreviations:** HIV, human immunodeficiency virus; MEMS, medication event monitoring system.
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###### 

Inclusion and exclusion criteria

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Domain                    Inclusion criteria                                                                                                                                                                                                                                                                                                                                                                                                         Exclusion criteria
  ------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study population          Study population ≥18 years, living in a Western country and using chronic preventive maintenance medication for one or more somatic, chronic condition as specified in the search strategy                                                                                                                                                                                                                                 Studies exclusively recruiting subpopulations in special conditions, like alcohol addicts, prisoners, pregnant women[\*](#tfn1-ppa-8-519){ref-type="table-fn"}

  Study types               Longitudinal retrospective or prospective study design, at least examining associations between predictor 'X' measured at baseline and outcome 'Y' measured ≥3 months after baseline^†^                                                                                                                                                                                                                                    Study is cross-sectional, controlled trial, case report, (systematic) review, meta-analysis, editorial, letter, comment, interview, newspaper article, case-control study, intervention study, thesis[\*](#tfn1-ppa-8-519){ref-type="table-fn"} or validation study[\*](#tfn1-ppa-8-519){ref-type="table-fn"}

  Outcome measure           Medication non-adherence is (one of) the primary outcomes of the study. All adherence instruments (eg, different questionnaires, refill data, MEMS) are eligible for inclusion                                                                                                                                                                                                                                             Outcome is discontinuation of medication

  Psychosocial predictors   Psychosocial predictors are defined as predictors, pertaining to the influence of social factors on an individual's mind or behavior, and to the interrelation of behavioral and social factors[@b18-ppa-8-519] The term psychosocial also covers internal, psychological predictors (eg, anxiety) in this systematic review. All predictor instruments (eg, different questionnaires/scales) are eligible for inclusion   Predictors measuring addiction to stimulating agents, psychosocial co-morbidity (eg, diagnosed depression according to DSM-IV criteria, and cognitive impairment. Illness symptoms, however, like depressive mood states and anxiety, are included in the review), socio-demographics, knowledge, cognitive status, behavior, satisfaction about treatment and health care, overall outcome measures (eg, social functioning of patient, general health status, perceived quality of life, behavioral intentions), predictors outside perception of individual patient (eg, beliefs of physicians)[\*](#tfn1-ppa-8-519){ref-type="table-fn"}\
                                                                                                                                                                                                                                                                                                                                                                                                                                                       In addition, predictors for which it was unclear what they measured (eg, 'HIV-mastery'[@b19-ppa-8-519] or 'coping' without specifying the type of coping), predictors for which results had not been reported in studies[\*](#tfn1-ppa-8-519){ref-type="table-fn"}

  Other                     English abstract available^‡^                                                                                                                                                                                                                                                                                                                                                                                              No English abstract available, unpublished studies which could not be retrieved after substantial efforts
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Notes:**

These criteria were formulated during the selection process. We did not exclude subpopulations based on socio-demographic features. Veterans or government employees, for example, are not in a special condition per se; ^†^when the outcome is measured multiple times after baseline, and one summary measure over the total, observational time after baseline is calculated, than the observational time should be at least 6 months. For example, studies measuring daily adherence for 3 months after baseline and calculating one summary adherence measure for a patient over these 3 months are excluded, because the mean time point of the summary adherence measure is 1.5 months after baseline; ^‡^please note that studies of all languages are eligible, but at least an English abstract should be available.

**Abbreviations:** DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision; HIV, human immunodeficiency virus; MEMS, medication event monitoring System.

###### 

Study characteristics and results[\*](#tfn3-ppa-8-519){ref-type="table-fn"}

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  First author                                                            Setting                                                                                                                                                                                     Sample characteristics                                  Measures and results                                                                                                                                                                                                                                                                                                                                                                          
  ----------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------- ------------------- -------------------------------------------------------------------- --------
  **Asthma (inhaled corticosteroids)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Ponieman[@b33-ppa-8-519]                                                USA; patients from general internal medicine clinic                                                                                                                                         261, 23%                                                48 (13), 82%                                                                                                             Age of onset ≤20 years: 50% of sample                                                Self-report (MARS), 3 months                                                           AI, n=5\            No (U: yes, M: no)\                                                  0 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   AIII, n=3           No (U: no, M: no)                                                    

  **Diabetes (oral and/or parenteral antidiabetics)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Venturini[@b34-ppa-8-519],[††](#tfn10-ppa-8-519){ref-type="table-fn"}   USA; patients from HMO-providing health services                                                                                                                                            786, 0%                                                 59 (mean), 24--92 (range), 49%                                                                                           NR                                                                                   Record review, last time point flexible, but within 24 months                          EI, n=1             No (U: NR, M: no)                                                    2 of 6

  **Heart disease and hypertension (cardiovascular medication)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Gazmararian[@b35-ppa-8-519]                                             USA; community-dwelling patients[‡‡](#tfn11-ppa-8-519){ref-type="table-fn"}                                                                                                                 1,549, UD                                               Age: 65--69: 35%, 70--74: 28%, 75--79: 20%, 80--84: 12%, \>84: 6%, (female): 58%                                         UD                                                                                   Record review, 12 months                                                               CIII, n=1           No (U: no, M: NT)                                                    3 of 6

  Nabi[@b26-ppa-8-519]                                                    Finland; local government employees                                                                                                                                                         1,021, UD                                               26--63 (range), 32%                                                                                                      0--2 years: n=311\                                                                   Record review, 12 months                                                               D, n=4\             Yes (U: no, M: yes)\                                                 1 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                       2--5 years: n=222\                                                                                                                                                          EI, n=2             No (U: no, M: NT)                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                       5--10 years: n=292\                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                       \>10 years: n=196                                                                                                                                                                                                                                                    

  Grégoire[@b36-ppa-8-519]                                                Canada; hypertensive adults with prescriptions from network of pharmacies                                                                                                                   692, 26%                                                59 (13), 56%                                                                                                             47 months (adherent group), 44 months (non-adherent group)                           Self-report (Morisky scale), 3 months                                                  AI, n=1\            No (U: no, M: no)\                                                   0 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   AII, n=5\           No (U: no, M: no)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   CIII, n=1           No (U: no, M: no)                                                    

  Miller[@b37-ppa-8-519]                                                  Site not reported: patients from institutions providing cardiac rehabilitation programs[¶¶](#tfn14-ppa-8-519){ref-type="table-fn"}                                                          141, 21%                                                56 (mean), 32--70 (range), 22%                                                                                           NR                                                                                   Self-report (HBS), 6--9 months                                                         AI, n=1\            No (U: NR, M: no)\                                                   0 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   CII, n=1            No (U: NR, M: no)                                                    

  Molloy[@b38-ppa-8-519]                                                  UK; patients admitted to hospitals with acute coronary syndrome[¶¶](#tfn14-ppa-8-519){ref-type="table-fn"}                                                                                  295, 11%                                                61 (mean), 32--87 (range), 23%                                                                                           0 years (acute)                                                                      Self-report, 12 months                                                                 CIII, n=2           No (U: no, M: no)                                                    1 of 6

  **HIV (antiretroviral medication)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Deschamps[@b25-ppa-8-519]                                               Belgium; outpatients at university hospital                                                                                                                                                 60, 28%                                                 43 (9) adherent group, 41 (8) non-adherent group, 16%                                                                    NR                                                                                   MEMS, 5--6 months after measuring psychosocial constructs                              AI, n=3\            No (U: no, M: NR)\                                                   1 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   AIII, n=1\          No (U: no, M: NR)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   BI, n=3\            No (U: no, M: NR)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   BII, n=4\           No (U: no, M: NR)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   CIII, n=2\          No (U: no, M: NR)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   D, n=1\             No (U: no, M: NR)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   EI, n=2             No (U: no, M: NR)                                                    

  Holmes[@b19-ppa-8-519]                                                  USA; HIV-clinic patients                                                                                                                                                                    116, 0%[§§](#tfn12-ppa-8-519){ref-type="table-fn"}      44 (median), 25--69 (range), 19%                                                                                         5 years (median)                                                                     MEMS, 12 months (or when viral load of ≥1,000 copies/mL was reached)                   AI, n=1\            No (U: no, M: no)\                                                   2 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   AII, n=2\           No (U: no, M: no)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   CI, n=1\            No (U: no, M: NT)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   CIII, n=1\          No (U: no, M: NT)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   EI, n=1\            No (U: no, M: no)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   EII, n=1            No (U: no, M: no)                                                    

  Delgado[@b39-ppa-8-519]                                                 Canada; patients enrolled in community drug treatment program                                                                                                                               316, 0%                                                 NR, NR                                                                                                                   NR                                                                                   Record review, 12 months                                                               EI, n=1             No (U: yes, M: no)                                                   1 of 6

  Singh[@b40-ppa-8-519]                                                   USA; new, veteran patients seen at medical center                                                                                                                                           52, 12%                                                 40 (median), 23--68 (range), 0%                                                                                          NR                                                                                   Record review, 6 months                                                                BII, n=1\           No (U: no, M: no)\                                                   1 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   CIII, n=2\          No (U: no, M: no)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   EI, n=4             No (U: no, M: no)                                                    

  Singh[@b41-ppa-8-519]                                                   Site not reported: patients in HIV-medical centers                                                                                                                                          138, 11%                                                41 (median), 24--71 (range), 7%                                                                                          NR (but 7% therapy-naive)                                                            Record review, 6 months                                                                BI, n=3\            No (U: no, M: NR)\                                                   1 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   BII, n=6\           No (U: no, M: NR)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   CIII, n=4\          No (U: no, M: NR)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   EI, n=1             No (U: no, M: NR)                                                    

  Bottonari[@b42-ppa-8-519]                                               USA; patients treated in immunodeficiency clinic                                                                                                                                            78, 69%                                                 36 (7), 4%                                                                                                               NR                                                                                   Self-report (straightforward), 6--9 months                                             D, n=2\             No (U: no, M: NR)\                                                   0 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   EI, n=1\            No: (U: no, M: NR)\                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   EII, n=3            No: (U: no, M: NR)                                                   

  Godin[@b43-ppa-8-519]                                                   Canada; patients from medicalHIV-clinics                                                                                                                                                    400, 6%                                                 43 (8), 4%                                                                                                               \>5 years HIV- infected: 73%                                                         Self-report (straightforward), 12 months                                               AI, n=1\            Yes (U: NR, M: yes)\                                                 1 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   AIII, n=2\          No (U: NR, M: no)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   CI, n=1\            No (U: NR, M: no)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   CIII, n=1\          No (U: NR, M: no)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   D, n=1              No (U: NR, M: no)                                                    

  Kacanek[@b44-ppa-8-519]                                                 USA; patients recruited by media and physician networks                                                                                                                                     225, 0%                                                 45 (7), 23%                                                                                                              NR                                                                                   Self-report (straightforward); maximum 30 months                                       EI, n=1             Yes (U: yes, M: NT)                                                  2 of 6

  Martini[@b45-ppa-8-519]                                                 Italy; outpatients using combination therapy[¶¶](#tfn14-ppa-8-519){ref-type="table-fn"}                                                                                                     214, 71%                                                \<30: 13%, 30--39: 56%, \>39: 31%, (female): 36%                                                                         NR                                                                                   Self-report (straightforward); 12 months                                               AI, n=2\            No (U: no, M: NR)\                                                   0 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   CI, n=1             Yes (U: yes, M: NR)                                                  

  Mellins[@b46-ppa-8-519]                                                 USA; HIV-infected mothers recruited in waiting room of adult clinic                                                                                                                         128, 25%                                                38 (mean), 22--66 (range), 100%                                                                                          5 years                                                                              Self-report (AACTG, straightforward), T1 after 4--5 months, T2 8--18 months after T1   AIII, n=1\          No (U: no, M: NR)\                                                   0 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   EI, n=1\            No (U: no, M: NR)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   EII, n=2            Yes (U: yes, M: NR)                                                  

  Nilsson Schönnesson[@b47-ppa-8-519]                                     Sweden; patients recruited by clinic nurses                                                                                                                                                 203, 29%                                                45 (9), 22%                                                                                                              Mean year of diagnosis =1990                                                         Self-report (straightforward), 24 months                                               AI, n=3\            No (U: NR, M: no)\                                                   1 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   AII, n=1\           No (U: NR, M: no)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   AIII, n=2\          No (U: NR, M: no)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   BII, n=2\           No (U: NR, M: no)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   CI, n=1\            No (U: NR, M: no)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   CIII, n=2\          No (U: NR, M: no)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   D, n=1\             No (U: NR, M: no)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   EI, n=3\            No (U: NR, M: no)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   EII, n=1            No (U: NR, M: no)                                                    

  Thrasher[@b48-ppa-8-519]                                                USA; patients in public use of HCSUS data set                                                                                                                                               1,911, 33%[§§](#tfn12-ppa-8-519){ref-type="table-fn"}   Minority versus non-minority: \<35: 35% minority group, 30% non-minority group. % female: 33% versus 12%, respectively   Mean year first diagnosed with HIV: 1992, minority group; 1990, non-minority group   Self-report (straightforward), 12 months                                               CIII, n=1 EI, n=2   No (U: no, M: NR) Yes (U: yes, M: NR)                                1 of 6

  Horne[@b49-ppa-8-519]                                                   UK; outpatients, eligible to receive HAART                                                                                                                                                  136, 14%                                                38 (9), NR                                                                                                               5 years                                                                              Self-report (straightforward), 12 months                                               AI, n=2\            Yes (U: yes, M: yes)\                                                3 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   EI, n=1             No (U: no, M: NT)                                                    

  Mugavero[@b50-ppa-8-519]                                                USA; patients receiving care at infectious disease clinics                                                                                                                                  474, 39%                                                40 (median), 35--46 (IQR), 29%                                                                                           NR                                                                                   Self-report (AACTG, straightforward), 27 months                                        EII, n=4            No (U: yes, M: no)                                                   3 of 6

  Carrieri[@b51-ppa-8-519]                                                France; patients starting HAART-regimen                                                                                                                                                     1,110, 13%                                              37 (median), 22%                                                                                                         First time since first positive HIV-test in years: 3.8 (median), 0.5--8.2 (IQR)      Self-report (AACTG, straightforward), 60 months                                        CII, n=1\           Yes (U: yes, M: yes)\                                                2 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   EI, n=1             Yes (U: yes, M: yes)                                                 

  **Transplant-related (immunosuppressant medication)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Stilley[@b52-ppa-8-519]                                                 USA; transplant patients, recruited before hospital discharge or at early clinic visit                                                                                                      152, 29%                                                55 (10), 33%                                                                                                             NR                                                                                   MEMS, 6 months                                                                         BI, n=1\            No (U: no, M: NR)\                                                   1 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   CII, n=1\           No (U: no, M: NR)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   D, n=2\             No (U: no, M: NR)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   EI, n=1             No (U: no, M: NR)                                                    

  De Geest[@b53-ppa-8-519]                                                Belgium; convenience sample of outpatients                                                                                                                                                  101, 0%                                                 56 (median), 20--69 (range), 13%                                                                                         3 (median), 1--6 (range) years since transplantation                                 MEMS, 6 months                                                                         AIII, n=1\          Yes (U: NR, M: yes)\                                                 2 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   CIII, n=1\          No (U: NR, M: no)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   EI, n=1\            No (U: NR, M: no)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   EII, n=1            No (U: NR, M: no)                                                    

  Russell[@b54-ppa-8-519]                                                 USA; convenience sample of renal transplant patients                                                                                                                                        50, 26%                                                 60 (5), 38%                                                                                                              NR                                                                                   MEMS, 12 months                                                                        AIII, n=1\          No (U: no, M: NR)\                                                   0 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   CIII, n=1\          No (U: no, M: NR)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   EI, n=2             No (U: no, M: NR)                                                    

  Weng[@b55-ppa-8-519]                                                    USA; patients recruited at time of renal transplantation                                                                                                                                    829, 66%                                                48 (median), 39--57 (IQR), 39%                                                                                           NR                                                                                   MEMS, 12 months post-transplantation                                                   AIII, n=1\          No (U: yes, M: no)\                                                  2 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   CII, n=1\           No (U: no, M: NT)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   EI, n=1\            No (U: no, M: NT)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   EII, n=1            No (U: no, M: NT)                                                    

  Dew[@b56-ppa-8-519]                                                     USA; heart transplant patients from academic hospital[\|\| \|\|](#tfn13-ppa-8-519){ref-type="table-fn"}                                                                                     108, 22%                                                \<50 years: 49%, (female): 16%                                                                                           NR                                                                                   Self-report (straightforward), 12 months post-transplantation                          AIII, n=1\          No (U: no, M: NT)\                                                   2 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   BI, n=2\            No (U: no, M: NT)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   BII, n=1\           Yes (U: yes, M: yes)\                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   CII, n=2\           No (U: no, M: no)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   EI, n=3             No (U: no, M: no)                                                    

  Dew[@b57-ppa-8-519]                                                     USA; patients receiving first lung transplantation in academic hospital                                                                                                                     178, 29%                                                37% \<50 years, (female): 48%                                                                                            NR                                                                                   Self-report (straightforward), 24 months                                               AIII, n=3\          No (U: yes[\*\*\*](#tfn15-ppa-8-519){ref-type="table-fn"}, M: no)\   1 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   CII, n=2\           No (U: yes, M: no)\                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   D, n=1\             No (U: yes, M: no)\                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   EI, n=3             No (U: yes, M: no)                                                   

  Dobbels[@b58-ppa-8-519]                                                 Belgium; heart, liver and lung transplant patients listed at university hospitals                                                                                                           186, 24%                                                52 (12), 33%                                                                                                             NR                                                                                   Self-report (straightforward), 12 months post-transplantation                          CII, n=2\           No (U: NR, M: no)\                                                   1 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   D, n=5\             No (U: NR, M: no)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   EI, n=2             No (U: NR, M: no)                                                    

  **Other (diabetes and/or hypertension and/or heart disease)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  DiMatteo[@b59-ppa-8-519]                                                USA; patients from five medical specialties in HMOs, large multispecialty groups or solo practices[‡‡](#tfn11-ppa-8-519){ref-type="table-fn"},[¶¶](#tfn14-ppa-8-519){ref-type="table-fn"}   Max 1,828, UD                                           60 (8), 54%                                                                                                              NR                                                                                   Self-report (straightforward), 24 months                                               BII, n=1\           No (U: NR, M: no)\                                                   0 of 6
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   CI, n=2\            No (U: NR, M: no)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   CII, n=1\           No (U: NR, M: no)\                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   EI, n=1             Yes (U: NR, M: yes)                                                  
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

NS (non significant): as reported in the concerning study. UD (undetermined): because of inadequate description in the concerning study;

mean (and for age: standard deviation) in years reported unless indicated otherwise;

with straightforward, we mean that participants were directly asked to indicate how many medication doses they missed. For example: "How many pills did you take this week?";

follow-up period = number of months between baseline (unless indicated otherwise) and last adherence measurement;

this column shows the number of psychosocial predictors measured in the concerning study, and the assigned psychosocial category. Details about the single predictors are presented in [Table S2](#SD3-ppa-8-519){ref-type="supplementary-material"}. A = Beliefs and cognitions about I) medication and treatment; II) illness; III) self-efficacy and locus of control. B = coping styles I) task oriented, II) emotion oriented. C = Social influences and social support I) regarding medical caregiver; II) regarding friends and family; III) in general. D = personality traits. E = psychological well-being: I) mood state; II) perceived stress/stressors;

no = no significant association between psychosocial category and medication adherence/non-adherence within study when *P*≤0.05; Yes = significant association when *P*≤0.05; U: univariate; M: multivariate;

to determine methodological quality, six bias domains per study were judged. Here, the total amount of bias free domains is reported (for further details, see [Table S3](#SD4-ppa-8-519){ref-type="supplementary-material"});

retrospective design;

diagnosis for coronary heart disease, hypertension, diabetes mellitus, and/or hyperlipidemia;

\% loss to follow-up assumed by HZ/BvdB;

type of medication is immunosuppressants, antihypertensives, and/or antivirals;

use of chronic preventive medication assumed;

significance of *P*≤0.05 assumed by HZ/BvdB.

**Abbreviations:** AACTG, adult AIDS clinical trials group; HAART, highly active antiretroviral therapy; HBS, health behavior scale; HCSUS, HIV cost and services utilization study; HIV, human immunodeficiency virus; HMO, health maintenance organization; IQR, interquartile range; MARS, medication adherence report scale; MEMS, medication event monitoring system; NR, not reported; NS, non significant; NT, not tested; UD, undetermined.

###### 

Level of evidence for longitudinal associations between psychosocial categories and medication non-adherence

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Psychosocial category                      N of studies   Quality   Longitudinal association                                                                                                                                                                                                                               Level of evidence
  ------------------------------------------ -------------- --------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -----------------------------------
  A. Beliefs and cognitions                                                                                                                                                                                                                                                                                                  

   I. About medication and treatment         9              All low   2 × yes[@b43-ppa-8-519],[@b49-ppa-8-519]\                                                                                                                                                                                                              No association (limited evidence)
                                                                      7 × no[@b19-ppa-8-519],[@b25-ppa-8-519],[@b33-ppa-8-519],[@b36-ppa-8-519],[@b37-ppa-8-519],[@b45-ppa-8-519],[@b47-ppa-8-519]                                                                                                                           

   II. About illness                         3              All low   3 × no[@b19-ppa-8-519],[@b36-ppa-8-519],[@b47-ppa-8-519]                                                                                                                                                                                               No association (limited evidence)

   III. Self-efficacy and locus of control   10             All low   1 × yes[@b53-ppa-8-519]\                                                                                                                                                                                                                               No association (limited evidence)
                                                                      9 × no[@b25-ppa-8-519],[@b33-ppa-8-519],[@b43-ppa-8-519],[@b46-ppa-8-519],[@b47-ppa-8-519],[@b54-ppa-8-519]--[@b56-ppa-8-519],[@b57-ppa-8-519]                                                                                                         

  B. Coping styles                                                                                                                                                                                                                                                                                                           

   I. Task-oriented                          4              All low   4 × no[@b25-ppa-8-519],[@b41-ppa-8-519],[@b52-ppa-8-519],[@b56-ppa-8-519]                                                                                                                                                                              No association (limited evidence)

   II. Emotion-oriented                      6              All low   1 × yes[@b56-ppa-8-519]\                                                                                                                                                                                                                               No association (limited evidence)
                                                                      5 × no[@b25-ppa-8-519],[@b40-ppa-8-519],[@b41-ppa-8-519],[@b47-ppa-8-519],[@b59-ppa-8-519]                                                                                                                                                             

  C. Social influences and social support                                                                                                                                                                                                                                                                                    

   I. Regarding medical caregiver            5              All low   1 × yes[@b45-ppa-8-519]\                                                                                                                                                                                                                               No association (limited evidence)
                                                                      4 × no[@b19-ppa-8-519],[@b43-ppa-8-519],[@b47-ppa-8-519],[@b59-ppa-8-519]                                                                                                                                                                              

   II. Regarding friends and family          6              All low   1 × yes[@b51-ppa-8-519]\                                                                                                                                                                                                                               No association (limited evidence)
                                                                      5 × no[@b37-ppa-8-519],[@b52-ppa-8-519],[@b55-ppa-8-519]--[@b57-ppa-8-519]                                                                                                                                                                             

   III. In general                           14             All low   14 × no[@b19-ppa-8-519],[@b25-ppa-8-519],[@b35-ppa-8-519],[@b36-ppa-8-519],[@b38-ppa-8-519],[@b40-ppa-8-519],[@b41-ppa-8-519],[@b43-ppa-8-519],[@b47-ppa-8-519],[@b48-ppa-8-519],[@b53-ppa-8-519],[@b54-ppa-8-519],[@b58-ppa-8-519],[@b59-ppa-8-519]   No association (limited evidence)

  D. Personality traits                      8              All low   1 × yes[@b26-ppa-8-519]\                                                                                                                                                                                                                               No association (limited evidence)
                                                                      7 × no[@b25-ppa-8-519],[@b42-ppa-8-519],[@b43-ppa-8-519],[@b47-ppa-8-519],[@b52-ppa-8-519],[@b57-ppa-8-519],[@b58-ppa-8-519]                                                                                                                           

  E. Psychosocial well-being                                                                                                                                                                                                                                                                                                 

   I. Mood state                             21             All low   3 × yes[@b44-ppa-8-519],[@b48-ppa-8-519],[@b51-ppa-8-519]\                                                                                                                                                                                             No association (limited evidence)
                                                                      18 × no[@b19-ppa-8-519],[@b25-ppa-8-519],[@b26-ppa-8-519],[@b34-ppa-8-519],[@b39-ppa-8-519]--[@b42-ppa-8-519],[@b46-ppa-8-519],[@b47-ppa-8-519],[@b49-ppa-8-519],[@b52-ppa-8-519]--[@b58-ppa-8-519]                                                    

   II. Perceived stress/stressors            8              All low   2 × yes[@b46-ppa-8-519],[@b59-ppa-8-519]\                                                                                                                                                                                                              No association (limited evidence)
                                                                      6 × no[@b19-ppa-8-519],[@b42-ppa-8-519],[@b47-ppa-8-519],[@b50-ppa-8-519],[@b53-ppa-8-519],[@b55-ppa-8-519]                                                                                                                                            
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
